,COMPOUND_ID,SMILES,BIOACTIVITY_IN_BRIEF,y
585,CMNPD586,CCCCC1C=CCC=CC1,,0
31446,CMNPD31447,CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CNCCCC[C@@H](C(=O)O)NC(=O)[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H]([C@@H](O)C(=O)O)NC(=O)[C@@H]4CS[C@@H](C)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)[N+](C)(C)C)CS[C@H]3C)C(=O)N[C@@H](CS[C@@H](C)[C@@H](NC(=O)[C@H](C(C)C)NC1=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N4)C(=O)N2,"Anti-HIV-1 IC 50 0.225 μM, cytotox. CC 50 2.63 μM",1
20204,CMNPD20205,O=C1C(c2ccc(O)c(OS(=O)(=O)O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(OS(=O)(=O)O)c2)C(=O)c2cc(O)c(O)cc2-3)-c2cc(O)c(O)cc21,anti-HIV active,1
40,CMNPD41,CC(=O)[C@H](Br)C[C@@H](Br)C(C)(C)Cl,,0
263,CMNPD264,NC(=O)CC1(O)C=C(Br)C(=O)C(Br)=C1,antibiotic | antimicrobial,0
11185,CMNPD11186,CCCCCCCC/C=C/CCCCCCCC(=O)NCCCOc1c(Br)cc(CCNC(=O)CCCCCCC/C=C/CCCCCCCC)cc1Br,inhibit HIV-1,1
31,CMNPD32,C#C/C=C\C[C@H]1OO/C(C(Br)CC)=C\C=C/C[C@H]1Cl,,0
326,CMNPD327,CC/C=C\C[C@H](O)[C@H](O)/C=C/[C@@H](O)CCCCCCCC(=O)O,,0
12749,CMNPD12750,C=C1CC[C@@H]2[C@H]3C(C(C)C)=C[C@H](O)[C@@]3(C)CC[C@@]2(C)C[C@H]1O,cytotoxic and anti-HIV–1 activity,1
207,CMNPD208,[C-]#[N+][C@]1(C)[C@H](C)C[C@@H]2C[C@H](C)C3CC[C@](C)([N+]#[C-])C4CC[C@H]1C2[C@H]34,,0
572,CMNPD573,C=C1CC[C@@H](O)[C@@]2(C)C[C@@H](O)C3=C(C(C)C)CC[C@]3(C)C[C@]12O,,0
13497,CMNPD13498,CC[C@H]1C=CCC[C@@]2(C[C@@H]3CC[C@@H]4[C@H](C(=O)OCCCCCCCCCCCCCCCCCC(=O)N(CCCN)CCCC(N)=O)[C@]5(CCC[C@@H](C)O5)N=C(N2)N34)O1,potent inhibitor of HIV-1 envelope-mediated fusion,1
293,CMNPD294,CC(=O)CC(=O)C1=C(C)CC(O)CC1(C)C,antimicrobial,0
483,CMNPD484,C=C(C)[C@@H]1CC[C@@]2(C)[C@H](O)CCC(=C)[C@@H]2C1,,0
12764,CMNPD12765,CC1=CC[C@@H]2[C@H]3C(C(C)C)=CC(=O)[C@@]3(C)C(=O)C[C@@]2(C)CC1=O,cytotoxic and anti-HIV–1 activity,1
26248,CMNPD26249,C=C(C)C=C=C1C[C@@H]2O[C@@H](C(C)(C)O)C[C@]2(Cl)[C@H](O)[C@@H]1O,"inactive, IA vs. H1N1 and HIV.",1
648,CMNPD649,C[C@H]1/C=C/CC2O[C@@H]2C[C@@H](Cl)[C@H]2C[C@H](O1)[C@@H](/C(Br)=C/Br)O2,,0
308,CMNPD309,O=P(NC1CCCCCCC1)(Oc1ccccc1)Oc1ccccc1,,0
30660,CMNPD30661,COc1c(O)cc2c(=O)c3c(oc2c1C(=O)O)C=C(C)OC3,No activation latent HIV. | No inhib. bromodomain-containing protein (BRD4).,1
29,CMNPD30,C#C/C=C/CC12OC(C(Br)CC)CC1(Cl)C=CC2O,,0
518,CMNPD519,CC(C)=CCC[C@@]1(C)[C@H]2/C=C(/C)C(=O)/C=C/[C@](C)(O)CC[C@@H]21,,0
651,CMNPD652,CC(Cl)(/C=C/[C@H](Cl)[C@](C)(Cl)/C=C/Cl)CBr,,0
5258,CMNPD5259,CCC(=O)OC(C/C=C(\C)C(=O)OC)C(C)C(OC(C)=O)C(CC(C)C(OC(=O)CC(C)C)[C@H]1C[C@@H](C)C[C@@]2(C[C@@H](C)C[C@H]([C@H](O)/C(C)=C/CCC(C)CC(=O)OC)O2)O1)OC(=O)CC(C)C,HIV-1 protease inhibitor,1
328,CMNPD329,CCCCC[C@@H](O)C[C@H](O)CCC/C=C/Cl,,0
83,CMNPD84,CC1(C)[C@H](Cl)C[C@@H]2OCC=C2[C@@H]1Br,,0
10,CMNPD11,CCCCCCCC(C/C=C/CCC(=O)N(C)C/C(Cl)=C/[C@@]12O[C@@H]1CC=C(C)C2=O)OC,,0
219,CMNPD220,C=C1[C@@H](O)C[C@@H]([C@H](C)CCC=C(C)C)[C@@H](O)[C@@H]2C(C)=CC[C@@H]12,,0
36,CMNPD37,C#C/C=C\[C@H]1C2C3CC4O[C@](Br)(C2C4O3)[C@]1(Br)CC,,0
221,CMNPD222,CC(C)=CCC[C@H](C)[C@@H]1CC[C@@]2(C)C=CC=C(C)[C@H]2[C@@H]1O,,0
32,CMNPD33,C#C/C=C\C[C@@H]1O[C@H](C/C=C(/Br)CC)[C@H](Br)C[C@@H]1Cl,,0
403,CMNPD404,CCCCCCCCCCCCCc1cc(O)cc(O)c1,,0
485,CMNPD486,Cc1ccc2c(c1)[C@H](C(C)C)CC[C@H]2C,,0
778,CMNPD779,C=C1CC[C@H](Br)C(C)(C)[C@@H]1/C=C/C(C)(O)[C@H]1CC[C@@](C)(O)[C@@H](Br)C1,,0
127,CMNPD128,C=C1CCC[C@]2(C)CCC[C@H](C(=C)C)C12,,0
396,CMNPD397,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCc1cc(=O)c2c(O)cc(O)cc2o1,,0
590,CMNPD591,C[As](C)(=O)C[C@@H]1CC[C@H](OCC(O)CS(=O)(=O)O)O1,,0
798,CMNPD799,CCCCC[C@H](O)/C=C/C1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O,,0
189,CMNPD190,COc1ccc(OC)c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)[C@H]2CC[C@@H](O)[C@@]3(C)O)c1,,0
152,CMNPD153,Cc1ccc2c(c1C)Cc1occc1CC2,,0
17887,CMNPD17888,CC[C@@H](C)C[C@@H](C)[C@@H](O)[C@@H](C)C(=O)N[C@H](CCCN)C(=O)N[C@@H](CCC(=O)O)[C@@H](O)[C@@H](O)C(=O)N[C@H](C(=O)N[C@H]1C(=O)N[C@H](CO)C(=O)N[C@H](CCCN)C(=O)N[C@@H](CC(C)C)C(=O)N(C)[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)OC)C(=O)N[C@H](CC(=O)O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]1[C@H](C)C(C)C)[C@@H](C)[C@@H](C)C(N)=O,inhibit HIV-1 infection in the nanomolar range with cytotoxicity at micromolar levels,1
627,CMNPD628,C#C/C=C\CC(Cl)[C@H]1C[C@@H](O)[C@H](O)/C=C\[C@@H](CC)O1,,0
181,CMNPD182,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=CC(O)C=CC1O,,0
465,CMNPD466,C/C(=C\CCC(C)O)CC/C=C(\C)CC(=O)CC(C)C,,0
459,CMNPD460,CC(=O)CC/C=C(\C)CCC/C(C)=C/C(=O)C=C(C)C,,0
369,CMNPD370,CC1=CCC[C@]23C[C@]24CC[C@]2(C)[C@@H]([C@H](C)CC(=O)CC(C)C)CC[C@@]2(C)C4CC[C@@H]13,ichthyotoxicity,0
691,CMNPD692,Cc1cc(O)c([C@]2(C)CC=C(CO)[C@@H]2C)cc1Br,,0
334,CMNPD335,COc1cc2c([nH]c3ccc(Cl)cc32)c(-c2ccccc2)c1C,,0
22,CMNPD23,C#C/C=C\C[C@@H]1O[C@@H](C(Br)CC)C[C@@H](Br)[C@H]2C[C@@H]1O2,,0
12059,CMNPD12060,CC(C)C(=O)C[C@@H](O)[C@@H](C)[C@H]1CC[C@@]2(C)C3=CC(=O)[C@]45O[C@H]4[C@H](O)[C@@H](O)C[C@]5(C)C3=C[C@@H](O)[C@]12C,inhibitor of HIV-1 integrase,1
423,CMNPD424,CC(C)=CCCC(C)(O)/C=C/C/C(C)=C/CC/C(C)=C/Cc1cc(O)cc(C)c1O,,0
29814,CMNPD29815,COC(=O)NCCc1ccccc1C(=O)NCCc1ccccc1C(=O)NCCc1ccccc1,weak anti-HIV | no AB activ.,1
720,CMNPD721,Cc1occc1[C@H]1CC[C@@](C)(Br)[C@H](Cl)C1,,0
173,CMNPD174,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CCc1ccoc1,,0
593,CMNPD594,CCCCC(Br)(Br)[C@H]1O[C@@H]1Br,,0
11377,CMNPD11378,C/C1=C\[C@@H]2OC(=O)[C@@H](CN(C)C)[C@@H]2CC/C(C)=C/CC/C(C(=O)O)=C/CC1,HIV-inhibitory agent,1
28062,CMNPD28063,CC(=O)O[C@H]1C[C@@]2(C)CC([C@@H]3CC=C(C)C(=O)C3)=C[C@@H](O)[C@@H]2[C@@]2(C)CCCC(C)(C)[C@H]12,"Similar level of induction of latent HIV-proviral gene expression as positive control, prostratin",1
64,CMNPD65,CC1=C(/C=C/Cl)C[C@H](Cl)[C@](C)(Cl)C1,,0
796,CMNPD797,CC[C@@H]1C[C@@H]1[C@H]1OC(=O)CCC/C=C\C/C=C\[C@H]2[C@H]1C[C@@H]1O[C@H]21,,0
183,CMNPD184,C/C(=C\Cc1cc(O)ccc1O)CCc1c(C)c(O)c(O)c(C=O)c1C,,0
357,CMNPD358,C=C1CCCC(C)(C)C1CCC1=CC(O)OC1=O,,0
142,CMNPD143,C=C1C(=O)O[C@H]2[C@H](OC(C)=O)[C@@H](C)CCC/C(C)=C/CC[C@@]3(C)O[C@@H]3C[C@@H]12,,0
338,CMNPD339,Brc1ccc2[nH]c(Br)c(-c3c(Br)[nH]c4ccc(Br)cc34)c2c1,,0
18,CMNPD19,CCC[C@@H](OC(C)=O)C1=C(Br)/C(=C\Br)OC1=O,antimicrobial | antifungal,0
692,CMNPD693,Cc1cc2c(cc1Br)C1(C)CC(O2)C(C=O)C1C,,0
212,CMNPD213,C=C(C)C1CC[C@@]2(C)C(=O)CCC(=C)[C@@H]2C1,,0
364,CMNPD365,CC(=O)O/C=C/C(=C/OC(C)=O)CC/C=C(/C=O)CC/C=C(\C)CCC=C(C)C,,0
607,CMNPD608,C#C/C=C\C[C@H]1O/C(=C(/Br)CC)C/C=C\C[C@H]1Cl,,0
622,CMNPD623,C#C/C=C/C[C@@H](OC(C)=O)[C@H]1C/C=C\C[C@@H](Br)[C@@H](CC)O1,,0
48,CMNPD49,C=C[C@@](C)(Cl)[C@@H](Cl)/C=C/C(=C)C(Cl)Cl,,0
187,CMNPD188,CC1=CCC[C@H]2[C@](C)(Cc3cc(O)ccc3O)[C@@H](C)CC[C@]12C,inhibit human immunodeficiency virus (HIV) in vitro,1
800,CMNPD801,CCCCC/C=C\C/C=C\C=C/C#CCCCC(=O)O,ichthyotoxic,0
638,CMNPD639,C#C/C=C/C[C@H]1O[C@@H](C(Br)C/C=C/CC)C[C@H]1OC(C)=O,,0
43,CMNPD44,CC(/C=C/[C@H](Cl)[C@](C)(Cl)/C=C/Br)=C\Br,,0
707,CMNPD708,CC1=CC[C@@H](Br)C(C)(C)[C@]12CC[C@](C)(O)[C@@H](Cl)C2,,0
29424,CMNPD29425,O[C@H](C1=NC[C@H](c2c[nH]c3cc(Br)ccc23)N1)c1c[nH]c2cc(Br)ccc12,Strong AB activ. vs. Gram (+) | IA vs. Gram (-) | strong anti-HIV activ. vs. 2 strains | mod. activ. vs 1 HTCL,1
91,CMNPD92,Cc1ccc([C@]2(C)CC[C@@H](Br)C2(C)C)cc1,,0
409,CMNPD410,CCOC(=O)CCCCCCCCc1oc(CC)cc1C,,0
669,CMNPD670,C[C@]1(Cl)C[C@@](C)(/C=C/Br)[C@@H](Br)C[C@H]1Cl,,0
205,CMNPD206,[C-]#[N+][C@]1(C)CC[C@H](C(C)C)[C@@H]2C=C(C)CC[C@@H]21,,0
4940,CMNPD4941,CC1=CCC[C@H]2[C@](C)(Cc3c(O)ccc(O)c3O)[C@@H](C)CC[C@]12C,cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities,1
486,CMNPD487,C=C1C=C2[C@H](C(C)C)CC[C@@H](C)[C@@H]2CC1,,0
80,CMNPD81,C=CC(Cl)(CBr)CCC(Br)C(C)(C)Cl,,0
270,CMNPD271,COC1=C(Br)C2OC(=O)C[C@@]2(O)C=C1Br,,0
604,CMNPD605,C#C/C=C/C/C=C\C/C=C\CCCCC,,0
728,CMNPD729,CC1(C)C2(Br)C=C[C@@](C)(O)C13C[C@H](Br)[C@@](C)(Cl)CC3O2,,0
819,CMNPD820,COc1cc2c(c(Br)c1OC)Cc1cc(OC)c(OC)c(Br)c1Cc1cc(OC)c(OC)c(Br)c1C2,,0
25012,CMNPD25013,C=C1C[C@H](OC(C)=O)[C@H]2[C@H](C(C)(C)OC(C)=O)CC[C@]2(C)/C=C/[C@H](C)CC[C@H]1O,evaluated in anti-HIV-1 assay system,1
292,CMNPD293,COC(CCC(C)C1O[C@]23CC(OC(=O)CC(C(C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)C1C)c1cccc(O)c1,toxin,0
787,CMNPD788,CC1=C[C@@H]2[C@H]3CC[C@H](C(C)C)[C@]3(C)CC[C@@](C)(O)[C@@H]2CC1,,0
125,CMNPD126,CC(C)[C@@H]1CC=C[C@H]2[C@H]3[C@@](C)(C=CC(=O)[C@@]3(C)O)CC[C@]12CBr,,0
72,CMNPD73,CC1=C(Cl)C[C@@H](/C(C)=C\Cl)O[C@@]1(O)C(Br)Br,,0
631,CMNPD632,C#C/C=C\[C@@H](Cl)C1C2CC3O/C(=C(/Br)CC)C1C3O2,apoptotic,0
353,CMNPD354,CCCCCCCCCCCCCC(=O)OCC/C(=C/OC(C)=O)C(C/C=C(\C)C#CC=C(C)C)OC(C)=O,,0
310,CMNPD311,COC1=CC(=O)N(C(=O)/C=C2\C=C(CO)C(=O)N2C)C1,,0
731,CMNPD732,C=C(C)[C@H]1C[C@@]23C(=C)[C@@H](C=C(Br)C2(C)C)O[C@@H]3O1,,0
175,CMNPD176,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=CC(=O)C=CC1=O,,0
49,CMNPD50,C=C[C@@](C)(Cl)[C@@H](Cl)/C=C/C(=C\Cl)C(Cl)Cl,,0
712,CMNPD713,CC1(C)C(Br)=C[C@H]2O[C@@]2(C)[C@]12CC=C(CO)C[C@@H]2O,,0
539,CMNPD540,C=C(C)[C@H](O)CCC(=C)[C@@H]1C[C@@H](O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
14,CMNPD15,CCCCC(Br)(Br)C(=O)C(Br)Br,,0
772,CMNPD773,CC1(C)C[C@@](O)(C[C@@H]2[C@H](O)C[C@]3(C)[C@@H](Br)CC[C@@](C)(O)[C@@H]23)CC[C@@H]1Br,,0
130,CMNPD131,C=C1[C@@H](O)C[C@H]2C[C@]3(C)[C@@H](O)CC(C)(C)[C@@H]3[C@@]12O,,0
261,CMNPD262,Oc1ccc(Oc2c(O)cc(Br)c(Br)c2Br)c(Br)c1,antimicrobial,0
637,CMNPD638,CC/C=C/C[C@@H](Br)[C@H]1C[C@H]2O[C@H](C=C=CBr)C[C@H]2O1,,0
5409,CMNPD5410,O=C(O)CCCC#CC#C/C=C/CCCC/C=C/C#CBr,inhibit the activity of HIV-1 protease,1
8,CMNPD9,CCCCCCCCCCCCCCCCC(=O)/C=C/Cl,,0
17,CMNPD18,CCC[C@@H](OC(C)=O)C1=C(Br)/C(=C/Br)OC1=O,antimicrobial | antifungal,0
243,CMNPD244,OCc1cc(Br)c(O)c(Br)c1,,0
437,CMNPD438,CC(C)=CCC[C@@](C)(O)[C@@H](O)CC/C(C)=C/CC[C@]1(C)C=Cc2cc(O)cc(C)c2O1,,0
11580,CMNPD11581,O=C1C(c2ccc(O)c(O)c2)=C2C(=C(c3ccc(O)c(O)c3)C(=O)N2CCc2ccc(O)cc2)c2cc(O)c(O)cc21,anti-HIV active,1
230,CMNPD231,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@]1(C)CCc2cc(O)cc(C)c2O1,,0
534,CMNPD535,C=C(C(O)C(O)/C=C(/C)COC(C)=O)[C@@H]1C[C@@H](O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
682,CMNPD683,CC1(C)C=C(C(Cl)CBr)[C@H](O)C[C@@H]1Br,toxic,0
10421,CMNPD10422,CCC(C)/C=C(C)/C=C\C(O)C(C)(O)C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1C(=O)N[C@H](COC)C(=O)NCC(=O)N[C@@H](C)C(=O)N(C)C([C@@H](C)O)C(=O)NC(C(OC)c2ccc(O)cc2)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]1C(C)C)[C@@H](C)[C@@H](C)C(N)=O)[C@H](C)N)[C@@H](C)O,cytotoxic | HIV-inhibitory,1
3,CMNPD4,C1SSCSSS1,antibiotic,0
237,CMNPD238,CCCCCc1cc(O)c2ccccc2n1,antibiotic,0
29813,CMNPD29814,COC(=O)NCCc1ccccc1C(=O)NCCc1ccccc1,weak anti-HIV | no AB activ.,1
615,CMNPD616,C#C/C=C\C[C@@H]1O/C(CCC)=C\C=C/C[C@@H]1Cl,,0
220,CMNPD221,CC(C)=CCC[C@@H](C)[C@@H]1CC[C@@]2(C)C=COC=C(C)[C@H]2[C@@H]1O,,0
722,CMNPD723,C=C1C[C@@H](OC(C)=O)[C@@H](Br)C(C)(C)[C@@]12C=C/C(=C\Br)CC2,,0
264,CMNPD265,COC1(OC)C(Br)=CC(O)(CC(N)=O)C=C1Br,,0
12039,CMNPD12040,CCC(=O)O[C@@H]1CC[C@]2(C)C3C[C@H](O)[C@]4(C)C5=C(CCC4[C@]3(C)CCC2[C@@]1(C)CC)[C@H](C)OC5=O,inhibitor of in vitro HIV-1 envelope-mediated fusion,1
411,CMNPD412,CCc1cc(C)c(CCCCCCCCC(=O)O)o1,,0
186,CMNPD187,CC12CC[C@H]3[C@]4(C)CC[C@H]5C(C)(C)CCC[C@]5(C)[C@H]4CC[C@]3(C)C1Cc1c(O)cc(O)c(O)c12,,0
408,CMNPD409,COC(=O)[C@@]1(O)CC(OC)=CC1=O,antibacterial,0
9728,CMNPD9729,C[C@@H]1CCC2=C(CCCC2(C)C)C2=C1CO[C@@]1(O)C=CC(=O)C=C21,inhibit HIV-1 in the NCI primary screen,1
566,CMNPD567,C=C1CC[C@@H](O)[C@@]2(C)C[C@@H](OC(C)=O)C3=C(C(C)C)CC[C@]3(C)C[C@]12O,,0
11565,CMNPD11566,CC(C)CC(=O)O[C@H]1C[C@H]2O[C@@]3(CCCCCCC(C(CCCCCCOCC(COS(=O)(=O)O)NS(=O)(=O)O)OS(=O)(=O)O)OC(=O)CNC(=O)/C=C/CCCCC[C@H]2O3)C1,inhibitor of HIV-1 integrase,1
405,CMNPD406,CCCCCCCCCCCCCc1cccc(O)c1,anti-inflammatory,0
174,CMNPD175,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=CC(=O)C=CC1=O,,0
12757,CMNPD12758,CC(C)C1=CC(=O)[C@]2(C)[C@H]1[C@H]1CC[C@](C)(OO)C=C[C@]1(C)C[C@@H]2O,cytotoxic and anti-HIV–1 activity,1
322,CMNPD323,CCCCCCCC(C)CC(C/C=C/CCC(=O)NC(COC)C(O)C1=CC(C)C(O)C(C)(C)C1=O)OC,,0
57,CMNPD58,C=C[C@@](C)(Cl)[C@@H](Cl)/C=C/[C@@](C)(Cl)CBr,,0
38,CMNPD39,CC(C)(Cl)[C@H](Br)C[C@@H](Br)[C@](C)(O)/C=C/Br,,0
41,CMNPD42,CC(=O)O/C(C)=C/CC=C(C)C,,0
458,CMNPD459,CC(=O)CC/C=C(\C)CCCC(C)CC(=O)CC(C)C,,0
271,CMNPD272,COc1c(Br)cc(O)c(CC(N)=O)c1Br,,0
162,CMNPD163,CC1=C(O)/C(=C/C(C)CCC/C(C)=C/CC/C(C)=C/CCc2ccoc2)OC1=O,,0
93,CMNPD94,C=C1CC[C@@](C)(c2ccc(C)cc2)[C@H]1C,,0
28,CMNPD29,C#C/C=C\C[C@H]1O/C(=C(/Br)CC)[C@H](O)/C=C\C[C@H]1Cl,antiviral,0
24824,CMNPD24825,CC(C)=CCC/C(C)=C/CC[C@@]1(C)C=Cc2c(cc3c(c2O)CNC3=O)O1,mod. inhib. of HIV-1,1
505,CMNPD506,CC(=O)OC1CC=C(C=O)C2(C=O)C(C(C)CCC=C(C)C)CCC12C,,0
418,CMNPD419,CC(C)=CCC/C(=C/CC/C(C)=C/CC/C(C)=C/CC1=CC(=O)C=C(C)C1=O)C(=O)O,,0
177,CMNPD178,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=CC(=O)C=CC1=O,,0
12758,CMNPD12759,CC(C)C1=CC(=O)[C@@]2(C)CC[C@@]3(C)C=C[C@@](C)(O)CC[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
532,CMNPD533,C=C(C(O)/C=C/C(C)(O)COC(C)=O)[C@@H]1C[C@@H](O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,antimicrobial,0
471,CMNPD472,CC(=O)CC/C=C(\C)CC[C@H]1C(C)(C)[C@@H]2CC[C@@]1(C)O2,,0
684,CMNPD685,CC1(C)C/C(=C\CO)C=C[C@@H]1O,,0
538,CMNPD539,C=C(C)[C@@H](O)CCC(=C)[C@@H]1C[C@@H](O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
542,CMNPD543,CC(C)=CC/C=C(/C)[C@@H]1CC[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@]12O,,0
478,CMNPD479,CC1=C[C@@H]2C(=C(C)CC[C@H]2C(C)C)CC1,,0
515,CMNPD516,CC(C)=CCC[C@@H](C)[C@@H]1CC/C(C)=C/C=C\C(C)=C\[C@@H]1O,,0
664,CMNPD665,C=C1C[C@@](C)(Cl)[C@@H](Cl)C[C@H]1/C=C/Cl,,0
455,CMNPD456,CC(=O)CCC/C(C)=C/CC/C(C)=C/CO,,0
108,CMNPD109,Cc1cc(C)c2c(c1C)C[C@H](Br)[C@@](C)(Cl)CC2,,0
281,CMNPD282,CC(C)=CCC/C(C)=C/Cc1cc(O)c(Br)cc1O,,0
799,CMNPD800,CCCCCC(O)/C=C/C=O,ichthyotoxic,0
272,CMNPD273,O=C1NCC(COc2c(Br)cc(C3CNC(=O)O3)cc2Br)O1,,0
268,CMNPD269,COC1=C(Br)C2OC2(CC(N)=O)C=C1Br,,0
404,CMNPD405,CCCCCCCCCCCCCc1cccc(O)c1C(=O)O,anti-inflammatory,0
248,CMNPD249,Oc1c(Br)cc(Oc2c(O)c(Br)c(Br)c(O)c2Br)c(Br)c1Br,,0
1,CMNPD2,[O-][S+]1CSSC1,antibiotic,0
450,CMNPD451,CC1(C)CCC[C@]2(C)[C@@H]1CC[C@](C)(O)[C@H]2Cc1cc(O)ccc1O,antimicrobial,0
771,CMNPD772,CC(=O)O[C@H]([C@@H]1[C@H](O)C[C@]2(C)[C@@H](Br)CC[C@@](C)(O)[C@@H]12)[C@@]1(O)CC[C@H](Br)C(C)(C)C1,,0
52,CMNPD53,C=C[C@@](C)(Cl)[C@H](Cl)/C=C/C(=C/Cl)C(Cl)Cl,,0
362,CMNPD363,CC(=O)OC=C(COC(C)=O)CC(=O)C/C(C)=C/CC/C(C)=C/CCC(/C=C/OC(C)=O)=C\OC(C)=O,,0
686,CMNPD687,C=CC1=CC(C)(C)[C@@H](O)[C@H](O)C1,"toxic, inhibitor of feeding by fish",0
393,CMNPD394,CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)c1c(O)cc(O)cc1O,,0
113,CMNPD114,C=C[C@@]1(C)CC[C@H]2C(C)(C)[C@@H](Br)CC[C@]2(C)O1,,0
533,CMNPD534,C=C(CCC=C(C)C)[C@@H]1C[C@@H](O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
294,CMNPD295,N=C1N[C@H]2[C@H](COC(N)=O)NC(=N)N3CCC(O)(O)[C@]23N1,toxin,0
438,CMNPD439,COc1cc(C)c2c(c1)C=C[C@@](C)(CC(O)/C=C(\C)CCCC(C)C(=O)CC=C(C)C)O2,,0
561,CMNPD562,C=C(C)[C@H]1CC[C@@]2(C)C[C@@H]3O[C@@]3(C)CC/C=C(\C)CC[C@H]12,antimicrobial,0
6649,CMNPD6650,C=C1CCC2=C(C)C(C)CCC2(C)C1Cc1cc(O)c(CC(=O)OC)cc1O,inhibit HIV reverse transcriptase,1
461,CMNPD462,CC(=O)CC/C=C(\C)CC/C=C(\C)CC(=O)CC(C)C,,0
199,CMNPD200,C=C1CCC[C@]2(C)CC[C@@H](C=C(C)C)[C@H]12,,0
227,CMNPD228,C[C@H]1/C=C/[C@@]2(C)CC[C@@H](C(C)(C)O)C2[C@@H](O)C[C@](C)(O)/C=C/C1,,0
20,CMNPD21,CCC[C@@H](OC(C)=O)C1=C(Br)[C@@](CBr)(OC)OC1=O,antimicrobial | antifungal,0
149,CMNPD150,C/C(=C\C(=O)OCc1ccoc1)CC/C=C(\C)Cc1cc(C)co1,,0
383,CMNPD384,CCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(O)CCCCCCCCCCCCCCC,,0
464,CMNPD465,C/C(=C\CCC(C)O)CCCC(C)CC(=O)CC(C)C,,0
86,CMNPD87,Cc1cc(O)c([C@]2(C)CC[C@@H]3C[C@@]32C)cc1Br,antibiotic,0
168,CMNPD169,C/C(=C\CCC(C)CC(=O)O)CCCc1coc(Cc2ccoc2)c1,,0
10567,CMNPD10568,C[C@@H]([C@H]1CCC2C3=C(CC[C@@]21C)[C@@]12CO[C@@](O)([C@@H](O)C1)C(C)(C)C2[C@@H](OS(=O)(=O)O)C3)[C@H]1C[C@@H]2C[C@@](C)(OC2(C)C)[C@H](CC[C@@H](C)[C@H]2CCC3C4=C(CC[C@@]32C)[C@]23CC[C@](O)(OC2)C(C)(C)C3=CC4)O1,inhibitor of HIV-1 integrase,1
66,CMNPD67,C[C@@]1(Cl)C[C@@](C)(Br)[C@H](/C=C/Cl)C[C@@H]1Br,,0
319,CMNPD320,CCCCCCC[C@@H](C/C=C/CCC(=O)O)OC,,0
767,CMNPD768,CC1(C)C/C(=C/[C@@H]2CC[C@]3(C)[C@@H](Br)CC[C@@](C)(O)[C@@H]23)CC[C@@H]1Br,,0
529,CMNPD530,C=C(C(O)/C=C/C(C)(C)O)[C@@H]1C[C@@H](O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
629,CMNPD630,C#C/C=C/[C@@H]1O[C@H]2C[C@@H]1O[C@H](CC)[C@@H](Br)C[C@@H]2Cl,,0
716,CMNPD717,C=C1C[C@@H](O)CC(C)(C)[C@]12CC[C@](C)(Br)[C@@H](Cl)C2,,0
683,CMNPD684,CC1(C)C/C(=C\CCl)C=C[C@@H]1O,,0
63,CMNPD64,C[C@@]1(Cl)C[C@@](C)(Br)[C@H](/C=C/Cl)C[C@@H]1Cl,,0
171,CMNPD172,CC(C)=CCC/C(C)=C/CC/C(C)=C/CCc1ccoc1,,0
158,CMNPD159,CC1(C)CCC[C@]2(C)[C@H]3CC=C4C(=O)OC[C@H]4[C@]3(C)CC[C@@H]12,,0
677,CMNPD678,CC1(C)C=C(/C=C/Br)[C@H](O)C[C@@H]1Br,toxic,0
247,CMNPD248,Oc1c(Br)cc(Cc2cc(Br)c(O)c(Br)c2)cc1Br,,0
185,CMNPD186,CC1=C(CC/C(C)=C/CO)C(C)(C)CCC1,,0
256,CMNPD257,O=S(=O)(O)Oc1cc(CO)c(Br)c(Br)c1OS(=O)(=O)O,,0
355,CMNPD356,CC(=O)O/C=C/C(=C/OC(C)=O)CC[C@@H]1C(C)=CCCC1(C)C,,0
479,CMNPD480,CC(C)[C@@H]1CC[C@@H](C)C23CC[C@@](C)(O)[C@@H]2[C@@H]13,,0
727,CMNPD728,CC1(C)C2(Br)C=C[C@@](C)(O)C13C[C@H](Br)[C@@](C)(O)CC3O2,,0
788,CMNPD789,CC1=CC2C(=C(C)CC[C@@]3(C)[C@@H](C(C)C)CC[C@H]23)CC1,,0
685,CMNPD686,CC1(C)C/C(=C/CO)C=C[C@@H]1O,inhibitor of feeding by fish,0
433,CMNPD434,COc1cc(C)c(O)c(C/C=C(\C)CC(O)/C=C(\C)CC/C=C(\C)C(O)CC=C(C)C)c1,,0
302,CMNPD303,N=C1N[C@H]2[C@H](COC(=O)NS(=O)(=O)O)NC(=N)N3CCC(O)(O)[C@]23N1,toxin,0
444,CMNPD445,Cc1cc(O)c(O)c2c1O[C@@]1(C2)[C@@H](C)CC[C@@H]2[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]21C,,0
213,CMNPD214,CC(=O)CCC/C(C)=C/CC/C(C)=C/COC(C)=O,,0
62,CMNPD63,CC(=O)OC[C@]1(C)C[C@@](Br)(CCl)[C@H](Cl)C[C@@H]1Cl,,0
658,CMNPD659,C=C(C)[C@@H](Br)C[C@H](Br)/C(C)=C/CCl,,0
13,CMNPD14,O=C(C=C(Br)Br)C(Br)Br,,0
591,CMNPD592,C[As](C)(=O)C[C@@H]1CC[C@H](OCC(O)COP(=O)(O)OCC(O)CO)O1,,0
138,CMNPD139,C=C(C)[C@H]1CCC2=C[C@@H](C[C@]3(C)O[C@H]3c3cc(C(=O)OC)c(o3)C1)OC2=O,,0
554,CMNPD555,CC(C)=CC/C=C(/C)C1CC=C(C)C23CCC(C)C2C13,,0
11,CMNPD12,CC(Br)C(=O)CBr,,0
760,CMNPD761,CC(C)C1=CC[C@]2(C)[C@@H](Br)CC[C@@](C)(O)[C@H]2C1,,0
427,CMNPD428,COc1cc(C)c(O)c(C/C=C(\C)CC(=O)/C=C(\C)CCCC(C)C(=O)CC=C(C)C)c1,,0
399,CMNPD400,CCCCCCCCCCCCCC/C=C1\CC(=O)c2c(O)cc(O)cc2O1,,0
524,CMNPD525,C=C1CC[C@@H]([C@H](C)CC[C@@H](O)C(C)(C)O)[C@@H](O)[C@@H]2C(C)=CC[C@@H]12,,0
784,CMNPD785,CC(C)[C@@H]1CC[C@H](O)[C@H]2[C@H]3[C@](C)(CC[C@@]21CBr)[C@@H](Br)CC[C@@]3(C)O,,0
571,CMNPD572,C=C1CCC[C@@]2(C)CC=C3C(C(C)C)=CC[C@]3(C)C[C@]12O,,0
23,CMNPD24,C#C/C=C\C[C@@H]1O[C@@H](C(Br)CC)C[C@@H]2O[C@H]1C[C@@H]2Br,,0
79,CMNPD80,C=C(Cl)C(Cl)(CBr)CCC(Cl)C(C)(C)Br,,0
25013,CMNPD25014,CC(=O)O[C@H]1/C=C(/C)C(O)CC[C@@H](C)/C=C/[C@@]2(C)CC[C@@H](C(C)(C)OC(C)=O)[C@H]12,evaluated in anti-HIV-1 assay system,1
163,CMNPD164,CC1=C(O)/C(=C/C(C)CC/C=C(\C)CC/C=C(\C)CCCc2ccoc2)OC1=O,antibiotics,0
223,CMNPD224,CC(=O)OC1CC(C)C2CC2C2=C(COC2=O)C1C(C)CCC=C(C)C,,0
628,CMNPD629,C#C/C=C\C[C@@H]1O[C@@H](CC)[C@@H](Br)C/C=C\C[C@@H]1Cl,,0
321,CMNPD322,CCCCCCCC(C)CC(C/C=C/CCC(=O)NC(COC)C(O)[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H](C)[C@H]1O)OC,,0
228,CMNPD229,C=C1CCC[C@@]2(C)[C@H](O)C=C3[C@](C)(CC[C@]3(O)C(C)C)C[C@]12O,cytotoxic | markedly inhibit growth of the P-388 leukemia,0
350,CMNPD351,CCCCC/C=C/C/C=C/CCCCCCCC(=O)OCC/C(=C/OC(C)=O)C(C/C=C(\C)C#CC=C(C)C)OC(C)=O,,0
581,CMNPD582,CC/C=C\[C@H]1C=CCC=CC1,pheromone,0
718,CMNPD719,C=C1C[C@H](O)[C@H](Br)C(C)(C)[C@@]12CC[C@@](O)(CCl)C(=O)C2,,0
526,CMNPD527,C=C1CC[C@@H](C(C)(O)CCC=C(C)C)[C@@H](O)[C@@H]2C(C)=CC[C@@H]12,,0
351,CMNPD352,CCCCCCCCCCCCCCCC(=O)OCC/C(=C/OC(C)=O)C(C/C=C(\C)C#CC=C(C)C)OC(C)=O,,0
502,CMNPD503,CC(=O)O[C@@H]1C(=O)C2=C1CC/C=C(\C)CC[C@H]2[C@@H](C)CCC=C(C)C,,0
29818,CMNPD29819,O=C(NCCc1ccccc1C(=O)NCCc1ccccc1)NCCc1ccccc1C(=O)NCCc1ccccc1,weak anti-HIV | no AB activ.,1
11913,CMNPD11914,CCC(C)(C)[C@H](NC(=O)[C@H](NC(=O)[C@@H]1CCCN1C(=O)C(NC(=O)[C@@H](C)NC=O)C(O)c1ccc(Br)cc1)C(C)(C)C)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CS(=O)(=O)O)C(=O)N[C@@H]1C(=O)N(C)[C@@H](CCC(N)=O)C(=O)N[C@H](C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](CC(=O)O)C(=O)O[C@@H]1C,HIV-inhibitory,1
729,CMNPD730,CC1=CC2OC3(Br)C=C[C@@](C)(O)C2(C[C@H]1O)C3(C)C,,0
12750,CMNPD12751,CC(C)C1=C[C@H](O)[C@@]2(C)CC[C@@]3(C)C[C@@H](O)[C@]4(C)O[C@@H]4C[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
136,CMNPD137,C=C1C(=O)OC2C[C@@]3(C)O[C@@H]3CC/C(C)=C/CC/C(C)=C/C[C@@H]12,,0
170,CMNPD171,C/C(=C\CCc1ccoc1)C[C@@H](O)C[C@H](C)CCCc1ccoc1,,0
617,CMNPD618,C#C/C=C\C[C@H]1O[C@@H]([C@H](Br)CC)C/C=C\C[C@H]1Cl,,0
616,CMNPD617,C#C/C=C/C[C@H]1O[C@@H]([C@H](Br)CC)C/C=C\C[C@H]1Cl,,0
582,CMNPD583,C=C/C=C/C=C\CC,,0
513,CMNPD514,CC(C)=CCC[C@@H](C)[C@@H]1CC[C@@]2(C)C=CC=C(C)C2[C@@H]1O,,0
277,CMNPD278,NC(=O)c1cc(Br)c(Br)[nH]1,,0
85,CMNPD86,CC1(C)C(Cl)C(C(Cl)CBr)=CC[C@H]1Br,,0
770,CMNPD771,CC1(C)C[C@@](O)([C@H](O)[C@@H]2[C@H](O)C[C@]3(C)[C@@H](Br)CC[C@@](C)(O)[C@@H]23)CC[C@@H]1Br,,0
210,CMNPD211,C=C(C)C1CC[C@@]2(C)[C@H](O)CCC(=C)[C@@H]2C1,,0
255,CMNPD256,OCc1cc(O)c(O)c(Br)c1Br,antibiotic,0
110,CMNPD111,CC1(C)O[C@](C)([C@H]2CC[C@](C)(Cl)[C@@H](Br)C2)[C@H](O)C[C@H]1Br,,0
241,CMNPD242,Oc1c(Br)cccc1Br,,0
8900,CMNPD8901,CCCCCCCCCCCCCCCC/C=C\CCC#CCCC(=O)O[C@H](C)C[C@H](CCC[C@@](C)(O)CC(=O)NCCS(=O)(=O)O)OC(C)=O,inhibit both DNA polymerase b and HIV reverse transcriptase,1
4942,CMNPD4943,CC(=O)OC1=C(C[C@@]2(C)[C@@H]3CCC=C(C)C3CC[C@@H]2C)C(=O)C=CC1=O,cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities,1
327,CMNPD328,CCCCCCCCC[C@@]1(CO)CC[C@@H](C)C(=O)O1,antimicrobial,0
303,CMNPD304,N=C1N[C@H]2[C@H](COC(=O)NS(=O)(=O)O)N(O)C(=N)N3CCC(O)(O)[C@]23N1,toxin,0
603,CMNPD604,C#C/C=C\C/C=C\C/C=C\CCCCC,,0
336,CMNPD337,C=CC[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](CCCCC)OC)OC)OC)OC)OC)OC)OC)OC)OC,,0
47,CMNPD48,CC(/C=C/[C@@H](Cl)[C@](C)(Cl)/C=C/Br)=C(Br)Br,,0
407,CMNPD408,C=C(COCC(O)COC(=O)CCCCCCCCCCCCCCCCCCC)C(=O)O,,0
12743,CMNPD12744,CC1=CC[C@]2(C)CC(=O)[C@]3(C)CC=C(C(C)C)[C@@H]3[C@H]2CC1,cytotoxic and anti-HIV–1 activity,1
246,CMNPD247,O=Cc1cc(Br)c(O)c(Br)c1,,0
238,CMNPD239,CCCCCCCc1cc(O)c2ccccc2n1,antibiotic,0
267,CMNPD268,CCCSC1(SCCC)C(Br)=CC(O)(CC(N)=O)C=C1Br,,0
766,CMNPD767,CC1(C)C[C@@]2(CC[C@H]1Br)O[C@@H]2[C@H]1CC[C@@]2(C)[C@H](Br)CC[C@](C)(O)[C@H]12,,0
549,CMNPD550,CC(=O)O[C@@H]1CC(=O)[C@H]([C@H]2C(C=O)=CC[C@H]2/C(C)=C\CC=C(C)C)[C@@H]1C,,0
680,CMNPD681,CC1(C)C=C2[C@H](O)CO[C@@H]2C[C@@H]1Br,,0
487,CMNPD488,CC(C)[C@@H]1CC[C@]2(C)O[C@@]3(C)CC[C@H]2[C@H]1C3,,0
278,CMNPD279,N#Cc1cc(Br)c(Br)[nH]1,,0
609,CMNPD610,C#C/C=C/C[C@H]1O/C(=C(/Br)CC)[C@H]2C=CC[C@@H]1O2,,0
154,CMNPD155,CC1CCCC2(C)c3occc3CCC12C,,0
413,CMNPD414,C=CCCCCCCC[C@@H](O)[C@H]1C[C@H](O)[C@H](CCCCC)O1,,0
251,CMNPD252,Brc1c[nH]c2ccccc12,,0
754,CMNPD755,CC1(C)[C@@H](Br)CC[C@]2(C)O[C@@H](CBr)C(CO)=CC[C@@H]12,,0
30950,CMNPD30951,O=C(O)c1cc(CO)c2c(=O)c3c(O)cc(O)cc3oc2c1,IA vs. 8 HTCLs and HIV-1.,1
434,CMNPD435,COc1cc(C)c(O)c(C/C=C(\C)CC/C=C(\C)CC[C@H](O)[C@](C)(O)CCC=C(C)C)c1,,0
620,CMNPD621,C#C/C=C/C[C@@H](Cl)[C@H]1C/C=C\C[C@@H](Br)[C@@H](CC)O1,,0
552,CMNPD553,CC(=O)OC1C[C@@H](/C(C)=C\CC=C(C)C)[C@@H]([C@H]2C(=O)C=C[C@H]2C)C1CO,,0
522,CMNPD523,CC(C)=CCC[C@@H](C)[C@@H]1CCC(C)=C2CC=C(C)C2C1,,0
504,CMNPD505,CC(C)=CCCC(C)C1CCC2(C)C(O)CC=C(C=O)C12C=O,,0
688,CMNPD689,C=CC1(O)CC[C@@H](O)C(C)(C)C1,,0
345,CMNPD346,CC(=O)O/C=C(/C=C/OC(C)=O)[C@H](C/C=C(\C)C#CC=C(C)C)OC(C)=O,antimicrobial | toxic to marine ciliates,0
713,CMNPD714,CC(=O)OC[C@@]12C[C@H](O)[C@@]3(C[C@@H]1O2)C(C)(C)C(Br)=C[C@H]1O[C@]13C,,0
316,CMNPD317,COCC1=C/C(=C\C(=O)N2CC(OC)=CC2=O)N(C)C1=O,,0
359,CMNPD360,CC(=O)O/C=C/C(=C/OC(C)=O)CC/C=C(\C)CC/C=C(\C)CCCC(C)C,,0
29906,CMNPD29907,CC[C@H](C)C(=O)O[C@@H]1C(=O)[C@@]2(OC(=O)C(C)C)[C@@]3(O)C[C@@]1(C)[C@H](CC(=O)OC)[C@@]3(C)[C@H]1CC[C@@]3(C)[C@H](c4ccoc4)OC(=O)C[C@]34O[C@]142,Strongly AV (HIV-1).,1
325,CMNPD326,CCCCCCCC(=O)[C@H](C)C(=O)N[C@H](Cc1ccc(OC)cc1)C(=O)N[C@H](C(N)=O)C(C)C,,0
145,CMNPD146,C=C1/C=C\[C@H](OC(C)=O)[C@@]2(C)[C@@H](OC(C)=O)C[C@@H](OC(C)=O)[C@@](C)(OC(C)=O)[C@@H]2[C@H](OC(C)=O)[C@]2(O)[C@@H](C)C(=O)O[C@H]2[C@H]1Cl,,0
490,CMNPD491,CC(C)=CCC[C@H](C)[C@H]1CC/C(C)=C/C/C=C(/C=O)[C@@H]1C=O,,0
474,CMNPD475,CC(=O)CC/C=C(\C)CCC(=O)C1(C)CCC1C(C)C,,0
765,CMNPD766,C=C1C[C@@]2(O)CC[C@@H](C)[C@@H]2CC(C)(C)C[C@H]1O,,0
58,CMNPD59,C=C[C@@](C)(Cl)[C@@H](Br)/C=C/[C@@](C)(Cl)CBr,,0
341,CMNPD342,COc1cc(Br)c(-c2c(Br)[nH]c3ccc(Br)cc23)c2cc[nH]c12,,0
30800,CMNPD30801,C=C(C)C#CC1=C[C@@H]2O[C@@H](C(C)(C)O)C[C@]23O[C@@H]3[C@@H]1O,potent inhib. H1N1 | weak inhib. HIV.,1
240,CMNPD241,Cc1cc(O)c2c(O)c3c(cc2c1)C(=O)c1c(O)cccc1C3=O,,0
148,CMNPD149,CC1(C)CCC=C(/C=C/Cc2ccoc2)C1,,0
26609,CMNPD26610,COC[C@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)CC(O)/C=C\C(C)CC(C)C)[C@@H](C)O)[C@H](C)N)[C@@H](C)[C@@H](C)C(N)=O)[C@@H](C)OC(=O)[C@H](C)N(C)C(=O)[C@@H]([C@H](OC)c2ccc(O)cc2)NC(=O)[C@H]([C@@H](C)O)N(C)C(=O)[C@H](CC(C)C)NC(=O)CNC1=O,potent HIV inhibit. (EC 50 27 nM in HIV-1RF infected CEM-SS T-cells) | less potent cytotox. (IC 50 373 nM) vs host cells.,1
306,CMNPD307,C=C(CO)C[C@@H]1C[C@H](O)[C@]2(C)O[C@@H]3C[C@@H]4O[C@@H]5C[C@]6(C)O[C@]7(C)CC[C@@H]8O[C@@H]9C[C@]%10(C)O[C@@H]%11C(C)=CC(=O)O[C@H]%11C[C@H]%10O[C@H]9C[C@@H](C)[C@H]8O[C@H]7C[C@H]6O[C@@]5(C)C/C=C\[C@H]4O[C@H]3C[C@H]2O1,ichthyotoxin,0
512,CMNPD513,CC(C)=CCCC(C)(O)[C@@H]1CC/C(C)=C/CC/C(C)=C/[C@@H]1O,,0
135,CMNPD136,CC1=C2CC/C(C)=C/CC[C@]3(C)O[C@H]3CC/C(C)=C/[C@@H]2OC1=O,,0
30945,CMNPD30946,C[C@H]1CC(=O)O[C@@H]1c1oc2cccc(O)c2c(=O)c1O,"Weak inhib, HIV-1. | IA vs. 8 HTCLs",1
376,CMNPD377,CCCCCCCCCCCCC/C=C/C(O)C(CO)NC(=O)CCCCCCCCCCCCC,,0
24825,CMNPD24826,CC(C)=CCC/C(C)=C/CC[C@@]1(C)C=Cc2c(O)cc3c(c2O1)CNC3=O,mod. inhib. of HIV-1,1
12755,CMNPD12756,CC(C)C1=CC(=O)[C@@]2(C)C(=O)C[C@@]3(C)C=C[C@@](C)(OO)CC[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
348,CMNPD349,CC(=O)O[C@@H](C/C=C(\C)C#CC=C(C)C)c1ccoc1,,0
157,CMNPD158,C=C1CCCC(C)C1(C)CCc1ccoc1,,0
439,CMNPD440,C/C(=C\CC/C(C)=C/Cc1cc(O)cc(C)c1O)CC/C=C(\C)CCC1OC1(C)C,,0
35,CMNPD36,C#C/C=C\[C@H]1C2C3CC4O[C@](Br)(C2C4O3)[C@@]1(Br)CC,,0
447,CMNPD448,CC(C)=CCC/C(C)=C/Cc1cc(O)cc(C)c1O,,0
147,CMNPD148,CC(/C=C/Cc1ccoc1)=C\C=C\C(C)C,,0
112,CMNPD113,C=CC(C)(O)CCC1C(C)=CC[C@H](Br)C1(C)C,,0
815,CMNPD816,Oc1cc(Cc2cc(O)c(O)c(Br)c2Br)c(Br)c(Br)c1O,,0
53,CMNPD54,C[C@@](Cl)(/C=C/Br)[C@@H](Cl)/C=C/C(=C/Cl)C(Cl)Cl,,0
6648,CMNPD6649,C=C1CC[C@@H]2C(C)(C)[C@@H](Br)CC[C@]2(C)[C@@H]1Cc1cc(O)c(C=O)cc1O,inhibit HIV reverse transcriptase,1
12747,CMNPD12748,CC(C)C1=C[C@H](O)[C@]2(C)[C@H]1[C@H]1CC[C@]3(C)O[C@@H]3C[C@]1(C)C[C@@H]2O,cytotoxic and anti-HIV–1 activity,1
415,CMNPD416,CC(C)=CCC/C(C)=C/C(O)C(O)/C(C)=C/CC/C(C)=C/CC1=CC(=O)C=C(C)C1=O,,0
77,CMNPD78,C=C(C)C(=C)CCC=C(C)C,,0
5404,CMNPD5405,O=C(O)CCCC#CC#C/C=C/CC/C=C/C#C/C=C/Br,inhibit the activity of HIV-1 protease,1
28057,CMNPD28058,CC(=O)O[C@@H]1C[C@@H]2C(CO)=C[C@]3(C[C@](C)(OC(C)=O)C[C@@H](/C=C(\C)CCC=C(C)C)O3)O[C@@H]2C=C1C,"Similar level of induction of latent HIV-proviral gene expression as positive control, prostratin",1
560,CMNPD561,C=C(C)[C@H]1C[C@@H](O)[C@@]2(C)C[C@@H]3O[C@@]3(C)CC/C=C(\C)CC[C@H]12,antimicrobial,0
269,CMNPD270,COC1=C(Br)[C@@H](O)[C@@](O)(CC#N)C=C1Br,,0
192,CMNPD193,CC1(C)CCC[C@]2(C)[C@@H]1CC[C@]1(C)Oc3ccc(O)cc3C[C@@H]21,,0
252,CMNPD253,Clc1c[nH]c2cc(Br)ccc12,,0
577,CMNPD578,C=C1[C@@H](O)CC[C@@]2(C)CC[C@]3(O)O[C@@]12C[C@@]3(C)CCC(=O)C(C)C,,0
6512,CMNPD6513,CC(C)CCC[C@@H](COS(=O)(=O)O)[C@H]1CCC2C3CC=C4C[C@H](O)[C@H](OS(=O)(=O)O)C[C@]4(C)C3CC[C@@]21C,cytoprotective against HIV-1,1
28515,CMNPD28516,CC1C[C@@]23OC(=O)C(C(=O)CC[C@H](C)O)=C2O[C@@]1(C)[C@@H](O)[C@@H]3/C=C/C(=O)O,"No AB vs. 12 strains | No anti-HIV-1 replication activ. (0.016 to 50 μg/mL), however some promotion of viral replication (10 to 50 μg/mL).",1
90,CMNPD91,C=C1CC[C@@](C)(c2ccc(C)cc2O)[C@H]1C,antibiotic,0
818,CMNPD819,Oc1c(O)c(Br)c(COCc2c(Br)c(O)c(O)c(Br)c2Br)c(Br)c1Br,antifungal,0
42,CMNPD43,C[C@](Cl)(/C=C/[C@H](Cl)[C@](C)(Cl)/C=C/Br)C(Br)Br,,0
274,CMNPD275,COC1=C(Br)[C@H](O)[C@@]2(C=C1Br)CC(C(=O)NCCCCNC(=O)C1=NO[C@]3(C=C(Br)C(OC)=C(Br)[C@@H]3O)C1)=NO2,,0
103,CMNPD104,CC(=O)[C@@H]1CC[C@]2(C1)C(C)=CC[C@@H](Br)C2(C)C,,0
51,CMNPD52,C=C[C@@](C)(Cl)[C@@H](Cl)/C=C/C(=C/Cl)C(Cl)Cl,,0
176,CMNPD177,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=CC(=O)C=CC1=O,,0
738,CMNPD739,CC1=CC[C@@]2(C)C(=C(C)[C@@H](O)C[C@@H]2C)CC1,,0
654,CMNPD655,C/C(=C\C[C@@H](Cl)[C@@](C)(Br)CCl)[C@@H](Cl)C(Br)Br,antimicrobial,0
774,CMNPD775,CC1(C)[C@H](Br)CC[C@]1(C)C1=C[C@]2(O)[C@](C)(O)CC[C@H](Br)[C@@]2(C)C[C@H]1O,,0
12763,CMNPD12764,CC1=CC(=O)[C@]2(C)CC[C@@]3(C)[C@H](C(C(C)C)=C[C@@H]3O)[C@H]2CC1,cytotoxic and anti-HIV–1 activity,1
730,CMNPD731,CC1=CC[C@H](C)[C@@]2(C)O[C@]3(C)CC[C@]12C[C@H]3O,,0
527,CMNPD528,C=C([C@@H]1C[C@@H](O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12)[C@@H]1O[C@@H]1[C@@H]1OC1(C)C,potent inhibitor of cell division,0
402,CMNPD403,CCCCCCCCCCCCCCCc1cc(O)cc(O)c1,,0
20117,CMNPD20118,CC[C@@H](C)[C@@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NC1C(=O)N[C@@H](CC(N)=O)C(=O)N(C)CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H]2CC(=O)N/C2=C(/C)C(=O)N[C@@H](CC(=O)NC(N)=O)C(=O)N[C@H](C)C(=O)N(C)[C@H]([C@@H](C)CC)C(=O)O[C@@H]1C)C(C)C)N(C)C(=O)[C@H](CC(N)=O)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@@H](Cc1ccccc1)NC(=O)COC,moderate inhibitor of cellular HIV-1 entry,1
580,CMNPD581,CC1=C(CC/C(C)=C/CCc2ccoc2)C(C(C)C)CC1=O,,0
60,CMNPD61,C=C1C[C@@](C)(/C=C/Cl)[C@@H](Cl)C[C@H]1Cl,,0
642,CMNPD643,C[C@@H]1O[C@H](C=C=CBr)/C=C/[C@H](Cl)CC2=CC[C@H](Br)[C@@H]1O2,,0
30947,CMNPD30948,C[C@]12C[C@@H](O)[C@]3(O)C(=O)c4c(O)cccc4O[C@@]3(CO1)[C@@H]2O,IA vs. 8 HTCLs and HIV-1.,1
84,CMNPD85,CC1(C)[C@H](Br)C[C@@H]2OCC=C2[C@@H]1Br,,0
12744,CMNPD12745,CC1=CC[C@]2(C)C=C[C@]3(C)C(=O)C=C(C(C)C)[C@@H]3[C@H]2CC1,cytotoxic and anti-HIV–1 activity,1
283,CMNPD284,C=C1CC[C@@H](Br)C(C)(C)[C@H]1Cc1cc(O)c(Br)cc1O,,0
449,CMNPD450,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1cc(O)ccc1O,antimicrobial,0
25,CMNPD26,C#C/C=C/CC1O[C@@H]2C[C@@H]1O[C@H](CC)[C@@H](Br)C[C@H]2OC(C)=O,,0
33,CMNPD34,C#C/C=C\C(Cl)C1C2CC3O/C(=C(/Br)CC)C1C3O2,,0
520,CMNPD521,CC(=O)O[C@H]1C[C@H]2[C@H](/C=C(/C)C(=O)/C=C/[C@]1(C)O)[C@]2(C)CCC=C(C)C,,0
630,CMNPD631,C#C/C=C\[C@H](Cl)[C@@H](O)[C@H]1C[C@H]2O[C@H]2C[C@H](Br)[C@@H](CC)O1,,0
12752,CMNPD12753,CC(C)C1=CC(=O)[C@@]2(C)C(=O)C[C@@]3(C)CC(=O)[C@]4(C)O[C@@H]4C[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
743,CMNPD744,CC(C)=CCC/C(C)=C1\CCC2(C)OC2C1,,0
793,CMNPD794,CC(=O)O[C@H]1C[C@@]2(C)C(=C[C@@H]1O)C(=O)C=C1C3CCC([C@@](C)(O)[C@@H](O)CCC(C)C)[C@@]3(C)CCC12,,0
75,CMNPD76,CC(/C=C\C(Cl)=C(\C)C(=O)C(Br)Br)=C/Cl,,0
608,CMNPD609,C#C/C=C/C[C@H]1O/C(=C(/Br)CC)[C@H](O)/C=C\C[C@H]1Cl,,0
386,CMNPD387,C=C1CC[C@@H](Br)C(C)(C)C1Cc1cc(OC)c(Br)cc1O,,0
565,CMNPD566,C=C1CC[C@@H](OC(C)=O)[C@@]2(C)C[C@@H](OC(C)=O)C3=C(C(C)C)CC[C@]3(C)C[C@]12O,,0
28514,CMNPD28515,CC1C[C@@]23OC(=O)C4=C2O[C@@]1(C)[C@@H](O)[C@@H]3/C=C/C(=O)O[C@@H](C)CCC4=O,No AB vs. 12 strains | No anti-HIV-1 replication activ. (0.016 to 50 μg/mL).,1
697,CMNPD698,Cc1ccc([C@]2(C)CC/C(=C/Br)[C@@H]2C)cc1Br,,0
202,CMNPD203,C[C@@H]1CC[C@@H]2[C@@H]1[C@H]1[C@@H](CCC2(C)NC=O)C1(C)C,,0
151,CMNPD152,CC1(C)CC=CC2=Cc3occc3C=C1C2,,0
777,CMNPD778,CC(=O)O[C@]1(C[C@@H]2CC[C@]34C(O)O[C@](C)(CC[C@@H]3Br)[C@@H]24)CC[C@H](Br)C(C)(C)C1,,0
790,CMNPD791,CC(C)(O)[C@H]1CC[C@](C)([C@H](O)CC[C@](C)(O)[C@H]2CC[C@@H]3O[C@H]([C@@]4(C)CC[C@H](Br)C(C)(C)O4)CC[C@@]3(C)O2)O1,,0
30803,CMNPD30804,C=C(C)C=C=C1C[C@@H]2OC(C)(C)[C@@H](O)C[C@@]2(O)[C@@H](Cl)[C@@H]1O,IA vs. H1N1 and HIV.,1
417,CMNPD418,CC(C)=CCCC(CCC/C(C)=C/CC/C(C)=C/CC1=CC(=O)C=C(C)C1=O)C(=O)O,,0
343,CMNPD344,Brc1ccc2c(c1)c(Br)c(Br)n2-c1c(Br)[nH]c2ccc(Br)c(Br)c12,,0
262,CMNPD263,Oc1ccc(Br)cc1Oc1ccc(Br)cc1,antimicrobial,0
689,CMNPD690,C=C1CC[C@@](C)(c2c(O)cc(C)c(Br)c2I)[C@H]1C,,0
132,CMNPD133,CC(=O)CCC(=O)C1(C)CCC(=O)O1,,0
260,CMNPD261,Oc1cc(Cc2c(O)c(Br)c(O)c(Br)c2O)c(Br)c(Br)c1O,,0
286,CMNPD287,NC1=N[C@H](O)[C@H]2[C@H]3O[C@]4(O)O[C@@H]([C@@H](O)[C@@]2(N1)[C@@H]4O)[C@]3(O)CO,toxic,0
643,CMNPD644,CC1OC1[C@@H]1C[C@@H]1[C@@H]1OC2=C(Br)C[C@@H](C=C=CBr)O[C@H]21,,0
372,CMNPD373,COC(=O)/C1=C/c2c([nH]c3ccccc23)/C(C(=O)OC)=C\c2c1[nH]c1ccccc21,plant growth regulator,0
626,CMNPD627,C#C/C=C/CC(Cl)[C@H]1C[C@@H](O)[C@H](O)/C=C\[C@@H](CC)O1,,0
20203,CMNPD20204,O=C1C(c2ccc(O)c(O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(OS(=O)(=O)O)c2)C(=O)c2cc(O)c(O)cc2-3)-c2cc(O)c(O)cc21,anti-HIV active,1
653,CMNPD654,C[C@@](Cl)(/C=C/Cl)[C@@H](Cl)/C=C/C(Cl)(CCl)CBr,,0
29819,CMNPD29820,O=C(NCCc1ccccc1)NCCc1ccccc1C(=O)NCCc1ccccc1C(=O)NCCc1ccccc1C(=O)NCCc1ccccc1,weak anti-HIV | no AB activ.,1
224,CMNPD225,CC(=O)O[C@H]1C/C(C)=C/CC[C@@H](C)/C=C/[C@@]2(C)CC[C@@H](C(C)(C)O)[C@H]12,,0
519,CMNPD520,CC(=O)O[C@@H]1C[C@H]2[C@H](/C=C(/C)C(=O)/C=C/[C@]1(C)O)[C@]2(C)CCC=C(C)C,,0
525,CMNPD526,CC(C)=CCC[C@@H](C)[C@@H]1CC[C@](C)(O)[C@@H]2CC=C(C)[C@H]2[C@@H]1O,antimicrobial,0
786,CMNPD787,C=C1CC[C@H](Br)[C@@]2(C)CC[C@]3(CBr)[C@H](C(C)C)CC=C[C@H]3[C@H]12,,0
747,CMNPD748,C=C1CC=CC(C)(C)C1C/C=C(/C)C(O)CBr,,0
290,CMNPD291,C[C@]1(O)C(=O)N2c3c([nH]c(=O)[nH]c3=O)NC[C@@]2(O)[C@H](C(=O)O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]2O)[C@]12C(=O)Nc1cc(Br)ccc12,toxin,0
587,CMNPD588,C=C/C=C\[C@H]1C=CC[C@H]1C=C,,0
523,CMNPD524,C=C1CC[C@@H]([C@H](C)CCC(=O)C(C)C)[C@@H](O)[C@@H]2C(C)=CC[C@@H]12,,0
574,CMNPD575,C=C1CC[C@@H](O)[C@@]2(C)CCC3=C(C(C)C)CC[C@]3(C)C[C@]12O,,0
20214,CMNPD20215,O=C(O)CN1C(=O)C(c2ccc(O)c(O)c2)=C2C1=C(c1ccc(O)c(O)c1)C(=O)c1cc(O)c(O)cc12,anti-HIV active,1
708,CMNPD709,CC1=CC[C@@H](Br)C(C)(C)[C@]12CC[C@H](C)C(=O)C2,,0
795,CMNPD796,CCCCC/C=C\C/C=C\CC(O)/C=C/C=C\C/C=C\C(=O)O,antimicrobial,0
389,CMNPD390,Oc1cc(O)cc(O)c1,,0
20208,CMNPD20209,O=C1C(c2ccc(O)c(OS(=O)(=O)O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(OS(=O)(=O)O)c2)C(=O)c2cc(O)c(OS(=O)(=O)O)cc2-3)-c2cc(O)c(O)cc21,anti-HIV active,1
687,CMNPD688,C=CC1=CC(C)(C)[C@H](O)C(O)C1,,0
544,CMNPD545,C=C(CCC=C(C)C)[C@@H]1CC[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@]12O,,0
467,CMNPD468,CC(=O)CC/C=C(\C)CC/C=C(\C)CCC1OC1(C)C,,0
494,CMNPD495,CC(C)=CCC[C@H](C)[C@@H]1CC/C(C)=C/C/C=C2/CO[C@@H](O)[C@@H]21,,0
361,CMNPD362,CC(=O)O/C=C/C(=C/OC(C)=O)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C,inhibit the growth of two marine bacteria,0
797,CMNPD798,CCCCC[C@H](O)/C=C/C1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,,0
320,CMNPD321,C=C(CNC)C/C(=C\C(=O)N1CC(OC)=CC1=O)OC,,0
711,CMNPD712,CC1(C)[C@H](Br)C[C@H]2O[C@@]2(C)[C@@]12CC[C@](C)(Cl)[C@@H](Br)C2,,0
26,CMNPD27,C#C/C=C/CC1O[C@@H]2C[C@H]1O[C@@H](C(Br)CC)C[C@H]2Br,,0
20119,CMNPD20120,CC[C@@H](C)[C@@H](C(=O)N(C)[C@@H](CC(N)=O)C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NC1C(=O)N[C@@H](CC(N)=O)C(=O)N(C)CC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H]2CC(=O)N[C@@]2(O)[C@H](C)C(=O)N[C@@H](CC(=O)NC(N)=O)C(=O)N[C@H](C)C(=O)N(C)[C@H]([C@@H](C)CC)C(=O)O[C@@H]1C)C(C)C)[C@H](C)CC)N(C)C(=O)[C@@H](Cc1ccccc1)NC(=O)COC,moderate inhibitor of cellular HIV-1 entry,1
442,CMNPD443,Cc1cc(O)cc2c1O[C@@]1(C2)[C@@H](C)CC[C@@H]2[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]21C,,0
531,CMNPD532,CC(=O)OC/C(=C\C=C\C(C)(O)COC(C)=O)[C@@H]1C[C@@H](OC(C)=O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
82,CMNPD83,CC1(C)[C@H](Cl)C[C@@H]2OCC=C2[C@H]1Br,,0
184,CMNPD185,COc1cc(C)c(CC/C(C)=C/CC2=CC(=O)C=CC2=O)c(C)c1C,,0
635,CMNPD636,CC[C@H](Br)[C@H]1C/C=C\C[C@@H]2O[C@H](C=C=CBr)C[C@@H]2O1,,0
65,CMNPD66,C[C@@]1(/C=C/Cl)C[C@@](Br)(CCl)[C@H](Br)C[C@@H]1Cl,,0
28058,CMNPD28059,CC(=O)O[C@]1(C)C[C@@H](/C=C(\C)C/C=C/C(C)(C)O)O[C@@]2(C=C(CO)[C@H]3CC(=O)C(C)=C[C@H]3O2)C1,"Similar level of induction of latent HIV-proviral gene expression as positive control, prostratin",1
14727,CMNPD14728,C/C=C/C=C/C(O)=C1/C(=O)C(C)=C(O)[C@@]2(C)OC(=O)[C@@](C)(NC(=O)/C=C/C(=O)O)[C@@H]12,active against HIV | neuroprotective potential | selectively active against L5178y cells,1
14013,CMNPD14014,CC(=O)O[C@]1(C)/C=C/C[C@@H](C)/C=C/[C@@]2(C)CC[C@@H](C(C)(C)O)[C@@H]2[C@@H](O)C1,strong anti-HSV-1 activity in vitro | little inhibition of HIV-1 reverse transcriptase,1
20206,CMNPD20207,O=C1C(c2ccc(O)c(O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(OS(=O)(=O)O)c2)C(=O)c2cc(O)c(OS(=O)(=O)O)cc2-3)-c2cc(O)c(O)cc21,anti-HIV active,1
650,CMNPD651,C[C@](Cl)(/C=C/[C@H](Br)[C@](C)(Cl)/C=C/Br)CBr,,0
693,CMNPD694,Cc1ccc([C@]2(C)CC[C@@H]3C[C@@]32C)c(O)c1Br,,0
621,CMNPD622,C#C/C=C/C[C@@H](Cl)[C@H]1CC=CC[C@@H]([C@H](Br)CC)O1,,0
97,CMNPD98,CC1(C)[C@@]2(C[C@H](Br)[C@@](C)(Cl)C[C@@H]2O)[C@]2(C)O[C@@H]2C2O[C@]21Br,,0
821,CMNPD822,Cn1c(Br)c(Br)c2ccc(Br)cc21,antimicrobial,0
226,CMNPD227,C/C1=C\[C@H](O)C[C@@H](C)/C=C/[C@@]2(C)CC[C@@H](C(C)(C)O)C2[C@@H](O)C1,,0
659,CMNPD660,C=C(C)[C@@H](Cl)C[C@H](Cl)/C(C)=C/CCl,,0
775,CMNPD776,CC(=O)O[C@]1(C[C@@H]2CC[C@]3(C)[C@@H](Br)CC[C@@](C)(O)[C@@H]23)CC[C@H](Br)C(C)(C)C1,,0
733,CMNPD734,C=C(C)[C@H]1C[C@@]23[C@@H](O1)O[C@]2(C)C=CC(=O)C3(C)C,,0
235,CMNPD236,Cc1cc(Oc2c(O)cc(C)c3c2CC2[C@]4(C)CC[C@H]5C(C)(C)[C@@H](O)CC[C@]5(C)C4CC[C@]2(C)O3)cc2c1O[C@@]1(C)CCC3[C@@](C)(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]34C)C1C2,,0
203,CMNPD204,[C-]#[N+][C@@H]1C(C(C)C)CC[C@@H](C)[C@@]12C=C(C)CC2,,0
724,CMNPD725,C=C1CC(=O)[C@H](Br)C(C)(C)[C@@]12CCC(C)=C(Cl)C2,powerful inhibitor of cell division and of assembly of microtubules,0
553,CMNPD554,CC(=O)OCC1C(OC(C)=O)C[C@@H](/C(C)=C\CC=C(C)C)[C@H]1[C@H]1C(=O)C=C[C@H]1C,,0
392,CMNPD393,CC/C=C\C[C@H](O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)c1c(O)cc(O)cc1O,,0
7,CMNPD8,CCCCCCCCCCCCCCCC[C@@]1(OC)C=C[C@@H](CC(=O)OC)OO1,,0
129,CMNPD130,C[C@@H]1CO[C@@]2(O)CCC3=C[C@@H](O)C[C@H](C)[C@@]3(C)[C@@H]12,,0
371,CMNPD372,CC1=CCC[C@]23C[C@]24CC[C@]2(C)[C@@H]([C@H](C)CC(O)CC(C)C)CC[C@@]2(C)C4CC[C@@H]13,ichthyotoxicity,0
368,CMNPD369,C=C(C)[C@@H](O)CC/C(C)=C/CC/C(C)=C/CC/C=C(\C)CC/C=C(\C)CCC=C(C)C,,0
735,CMNPD736,C=C(C)[C@H]1C[C@@]23[C@@H](O1)O[C@]2(C)[C@@H](Cl)C=C(Br)C3(C)C,,0
88,CMNPD89,Cc1cc2c(cc1Br)[C@]1(C)CC[C@H](C)[C@]1(C)O2,,0
816,CMNPD817,COCc1cc(O)c(O)c(Br)c1Cc1cc(O)c(O)c(Br)c1Br,,0
26452,CMNPD26453,CO[C@H]1OC/C2=C/C/C=C(\C)C[C@@H](O)[C@@H]([C@H](C)CCC=C(C)C)[C@@H]21,inactive against wild-type HIV-1,1
92,CMNPD93,Cc1ccc([C@]2(C)CC[C@H](Br)C2(C)C)cc1,,0
26453,CMNPD26454,C=C(C)C(CC[C@@H](C)[C@@H]1[C@H](O)C/C(C)=C/C/C=C(/C=O)[C@H]1COC(C)=O)OC(C)=O,inactive against wild-type HIV-1,1
287,CMNPD288,N=C1N[C@H]2[C@H](COC(N)=O)NC(=N)N3CCC(O)(O)[C@]23N1,toxic,0
441,CMNPD442,Cc1cc(O)cc2c1O[C@@]1(C)CC[C@H]3[C@@](C)(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]34C)[C@H]1C2,,0
576,CMNPD577,C=C1CC[C@@H](O)[C@@]2(C)CCC3=C(C(C)C)CC[C@]3(C)C[C@H]12,,0
5257,CMNPD5258,CCC(=O)OC(C/C=C(\C)C(=O)OC)C(C)C(OC(C)=O)C(CC(C)C(OC(=O)CC(C)C)[C@H]1C[C@@H](C)C[C@@]2(C[C@@H](C)C[C@H]([C@H](O)C(C)=O)O2)O1)OC(=O)CC(C)C,HIV-1 protease inhibitor,1
172,CMNPD173,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CCc1ccoc1,,0
484,CMNPD485,C=C(C)[C@@H]1CC[C@@]2(C)C(=O)CCC(=C)[C@@H]2C1,,0
473,CMNPD474,CC(=O)CC/C=C(\C)CC/C=C(\C)C1CCC(C)(C)O1,,0
477,CMNPD478,C=C1CCC23[C@@H]([C@@H]12)[C@H](C(C)C)CC[C@H]3C,,0
758,CMNPD759,CC(C)[C@H]1CC[C@]2(C)[C@@H](Br)CC[C@@](C)(O)[C@H]2[C@@H]1Cl,,0
12052,CMNPD12053,CCCC(=O)OC(C(CC)C(C)C)C(OC(=O)CCC)[C@@H](C)[C@H]1[C@@H](O)[C@H](OC(C)=O)C2C3CCC4C[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)C[C@]4(C)C3CC[C@@]21C,anti-HIV-1 reverse transcriptase activity,1
431,CMNPD432,COc1cc(C)c(O)c(C/C=C(\C)CC(=O)/C=C(/C)CCC[C@@H](C)[C@@H](O)CC=C(C)C)c1,,0
27,CMNPD28,C#C/C=C/CC(O)C(O)C/C=C/C/C=C/CC,,0
410,CMNPD411,CCCCc1cc(C)c(CCCCCCCCC(=O)OCC)o1,,0
14205,CMNPD14206,O=CC1=C[C@@]23CC/C=C\CCCCN4CC[C@@H]1[C@@]1(C4)C[C@]4(CCC(=O)CCCN4[C@H]12)O3,potent antiinflammatory | antifungal | anti-HIV-1 agent,1
229,CMNPD230,C=C1CCC[C@@]2(C)[C@H](OC(C)=O)C=C3[C@](C)(CC[C@]3(O)C(C)C)C[C@]12O,cytotoxic | markedly inhibit growth of the P-388 leukemia,0
87,CMNPD88,Cc1ccc([C@]2(C)CC[C@@H]3C[C@@]32C)c(O)c1,,0
496,CMNPD497,CC(C)=CCC[C@H](C)[C@H]1[C@@H](O)C/C(C)=C/C/C=C(/C=O)[C@@H]1C=O,antimicrobial,0
25001,CMNPD25002,CC(=O)O[C@H]1/C=C(C)/C=C\C=C(/C)C(=O)C[C@@H]2[C@]1(C)CC[C@@]2(O)C(C)C,"evaluated against HIV-1, H5N1and LPS-induced NO production",1
481,CMNPD482,CC1=C[C@H]2[C@H](C(C)C)CC[C@@H](C)[C@]2(O)CC1,,0
596,CMNPD597,CCCCCC(=O)/C(Br)=C(/Br)I,,0
6,CMNPD7,CN(C)C1CSSC1,insecticidal | neurotoxic,0
295,CMNPD296,N=C1N[C@H]2[C@H](COC(N)=O)N(O)C(=N)N3CCC(O)(O)[C@]23N1,toxin,0
275,CMNPD276,COC1=C(Br)[C@H](O)[C@@]2(C=C1Br)CC(C(=O)NCCCCCNC(=O)C1=NO[C@]3(C=C(Br)C(OC)=C(Br)[C@@H]3O)C1)=NO2,,0
25007,CMNPD25008,CC(=O)OC/C1=C/C/C=C(\C)C[C@@H](O)[C@H]([C@H](C)CCC=C(C)C)[C@@H]1CO,"evaluated against HIV-1, H5N1and LPS-induced NO production",1
4519,CMNPD4520,CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)c2csc(n2)CNC(=O)c2csc(n2)[C@H](CCC(N)=O)NC1=O,"minor cytotoxic, inhibitor of HIV-1 integrase",1
11186,CMNPD11187,CCCCCCCCCCCCC(=O)NCCCOc1c(Br)cc(CCNC(=O)CCCCCCCCCCCC)cc1Br,inhibit HIV-1,1
30802,CMNPD30803,CC(C)=C/C=C1/C[C@@H]2O[C@@H](C(C)(C)O)C[C@]23O[C@@H]3[C@@H]1O,IA vs. H1N1 and HIV.,1
15913,CMNPD15914,CN(CCS(=O)(=O)O)C(=N)N,HIV-1 active,1
116,CMNPD117,C=C[C@@]1(C)CC[C@@]2(O1)C(C)=CC[C@H](C)[C@H]2C,,0
128,CMNPD129,C[C@@H]1CC[C@@H]2[C@@]3(C)C[C@H]3CC(C)(C)C[C@]12O,,0
300,CMNPD301,N=C1N[C@H]2[C@H](COC(=O)NS(=O)(=O)O)NC(=N)N3C[C@H](OS(=O)(=O)O)C(O)(O)[C@]23N1,toxin,0
421,CMNPD422,CC(C)=CCC/C(C)=C/C(O)C(O)/C(C)=C/CC/C(C)=C/Cc1cc(O)cc(C)c1O,,0
25002,CMNPD25003,CC(=O)O[C@H]1/C=C(C)/C=C\C=C(\C)C(=O)C[C@@H]2[C@]1(C)CC[C@@]2(O)C(C)C,"evaluated against HIV-1, H5N1and LPS-induced NO production",1
702,CMNPD703,C=C1CC[C@@](C)(C2=CCC(COC(C)=O)=CC2)[C@H]1C,,0
492,CMNPD493,CC(=O)OC[C@H]1/C(C=O)=C\C/C=C(\C)C[C@H](O)[C@@H]1[C@@H](C)CCC=C(C)C,,0
586,CMNPD587,C=C/C=C\C1C=CCC=CC1,,0
6013,CMNPD6014,C#CC(O)/C=C/C(O)C/C=C\CC(O)C#CC(O)C#CC(O)CCC/C=C\CCCC(O)C(=O)CCCCCCCCCCCC(O)CC(O)C#CC(=O)O,inhibit HIV reverse transcriptase,1
101,CMNPD102,C=C1CC[C@H](Br)C(C)(C)[C@]12CC[C@](C)(Cl)[C@@H](Br)C2,,0
703,CMNPD704,C=C1CC[C@@](C)(c2ccc(CO)cc2)[C@H]1C,,0
4,CMNPD5,C1SCSSCS1,antibiotic,0
34,CMNPD35,C=C=C/C=C/C1C2CC3O/C(=C(/Br)CC)C1C3O2,,0
678,CMNPD679,CC1(C)C=C(/C=C/Br)[C@@H](O)C[C@@H]1Br,,0
668,CMNPD669,C[C@]1(/C=C/Cl)C[C@@](C)(Cl)[C@@H](Br)C[C@@H]1Br,,0
2687,CMNPD2688,C#C[C@@H](O)/C=C/CCCCCCC#C[C@@H](O)/C=C\[C@H](O)C#CCCCCCC/C=C/[C@H](O)C#C,inhibit HIV reverse transcriptase,1
584,CMNPD585,C=C[C@@H]1CC=CC[C@H]1/C=C/C,,0
374,CMNPD375,CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)CCCCCCCCCCCCCC,,0
20209,CMNPD20210,O=C1C(c2ccc(O)c(O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(OS(=O)(=O)O)c2)C(=O)c2cc(O)c(OS(=O)(=O)O)cc2-3)-c2cc(OS(=O)(=O)O)c(O)cc21,anti-HIV active,1
564,CMNPD565,C=C1CC[C@@H](OC(C)=O)[C@@]2(C)CC=C3C(C(C)C)=CC[C@]3(C)C[C@]12O,,0
331,CMNPD332,CO[C@@H](CC[C@H](C)C1O[C@@]23C[C@H](OC(=O)C[C@H](CO)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C)c1cc(O)c(Br)cc1Br,toxic,0
360,CMNPD361,CC(=O)O/C=C/C(=C/OC(C)=O)CC[C@@H]1C(C)=CC[C@@H]2C(C)(C)CCC[C@@]12C,,0
822,CMNPD823,Cn1c(Br)c(Br)c2cc(Br)ccc21,antimicrobial,0
315,CMNPD316,COCC1=C/C(=C/C(=O)N2CC(OC)=CC2=O)N(C)C1=O,,0
169,CMNPD170,C/C(=C\CCc1ccoc1)CC/C=C(\C)CCCc1ccoc1,,0
344,CMNPD345,CC(=O)O/C=C/C(=C/OC(C)=O)CC/C=C(\C)CCC=C(C)C,,0
495,CMNPD496,COC1O[C@@H](OC)[C@H]2/C1=C\C/C=C(\C)C[C@H](OC(C)=O)[C@H]2[C@@H](C)CCC=C(C)C,,0
198,CMNPD199,C=C1CCC[C@]2(C)CC[C@@H]([C@@H](NC=O)C(C)C)[C@H]12,,0
166,CMNPD167,CC1=C(O)/C(=C/C(C)CC/C=C(\C)CCCc2coc(Cc3ccoc3)c2)OC1=O,,0
709,CMNPD710,CC1=CC[C@@H](Br)C(C)(C)[C@]12CC[C@](C)(Cl)[C@@H](Br)C2,,0
468,CMNPD469,C=C1CC[C@H](O)C(C)(C)[C@@H]1CC/C(C)=C/CCC(C)=O,,0
469,CMNPD470,CC(=O)CC/C=C(\C)CC[C@@H]1C(C)=CC[C@H](O)C1(C)C,,0
373,CMNPD374,CCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)CCCCCCCCCCCCCC,,0
285,CMNPD286,CC(C)=CCC/C(C)=C/C(=O)c1cc(O)c(Br)cc1O,,0
801,CMNPD802,CCCCC/C=C\C/C=C\C(O)CC#CCCCC(=O)O,ichthyotoxic,0
503,CMNPD504,CC(=O)O[C@H]1C[C@H](C)[C@H]2C[C@H]2C2=C(COC2=O)[C@H]1[C@@H](C)CCC=C(C)C,,0
96,CMNPD97,CC1(C)C(Br)=C[C@H]2O[C@@]2(C)[C@]12C[C@H](Br)[C@@](C)(Cl)C[C@@H]2O,,0
387,CMNPD388,OCc1cc(Br)c(O)c(O)c1Cc1ccc(O)c(Br)c1,antibacterial | toxic,0
714,CMNPD715,C=C1C[C@@H](O)[C@@H](Br)C(C)(C)[C@]12CC[C@](C)(Br)[C@@H](Cl)C2,,0
674,CMNPD675,CC1(C)[C@@H](Br)C[C@H](Cl)/C(=C\CBr)[C@@H]1Cl,,0
6941,CMNPD6942,CC(C)[C@@H](C)CC[C@@H](C)[C@H]1CCC2C3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)C[C@]4(C)C3CC[C@@]21C,inhibit HIV in vitro,1
297,CMNPD298,N=C1N[C@H]2[C@H](COC(N)=O)NC(=N)N3C[C@H](OS(=O)(=O)O)C(O)(O)[C@]23N1,toxin,0
460,CMNPD461,CC(=O)CC/C=C(\C)CC/C=C(\C)CC(=O)C=C(C)C,,0
9,CMNPD10,CCCCCCCC(C/C=C/CCC(=O)N(C)C/C(Cl)=C/[C@@]12O[C@@H]1C[C@H](OC(C)=O)[C@H](C)C2=O)OC,,0
10423,CMNPD10424,CC=C(NC(=O)[C@H](NC(=O)CNC(=O)C(C)(O)C(O)/C=C\C(C)=C\C(C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H]1C(=O)N[C@H](COC)C(=O)NCC(=O)N[C@@H](C)C(=O)N(C)C([C@@H](C)O)C(=O)NC(C(OC)c2ccc(O)cc2)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]1C(C)C)[C@@H](C)[C@@H](C)C(N)=O,cytotoxic | HIV-inhibitory,1
757,CMNPD758,C=CC(C)(O)CCC1=C(C)C2CC2C1(C)C,,0
521,CMNPD522,C=C1CC[C@@H]([C@H](C)CCC=C(C)C)C[C@@H]2C(C)=CC[C@@H]12,,0
601,CMNPD602,C#C/C=C\C/C=C\C/C=C\C/C=C\CC,,0
558,CMNPD559,C/C1=C\CC[C@H](C)/C=C/[C@]2(C)CC[C@H](C(C)(C)O)[C@H]2CC1,antimicrobial,0
676,CMNPD677,CC1(C)[C@@H](Br)CC=C(/C=C/Br)[C@@H]1Cl,toxic,0
124,CMNPD125,C=C[C@](C)(O)CC[C@]1(O)[C@@H](C)CC[C@@H]2C(C(C)(C)OO)=CC[C@]21C,,0
634,CMNPD635,CC[C@H](Br)[C@H]1C/C=C\C[C@@H]2O[C@@H](C=C=CBr)C[C@@H]2O1,,0
618,CMNPD619,C#C/C=C/C[C@@H]1O[C@@H]([C@@H](Br)CC)C[C@H](OC(C)=O)[C@@H](Cl)C[C@@H]1Cl,,0
614,CMNPD615,C#C/C=C\C[C@H]1O/C(=C(\Br)CC)C/C=C\C[C@H]1Cl,,0
715,CMNPD716,C=C1C[C@H](O)[C@H](Br)C(C)(C)[C@@]12CC[C@](C)(Br)[C@@H](Cl)C2,,0
365,CMNPD366,CC(C)=CCC/C(C)=C/CC/C(C=O)=C\CCc1ccoc1,antimicrobial,0
741,CMNPD742,CC1(C)[C@@H](Br)[C@@H](O)C[C@]2(O)C[C@]3(C)CC[C@]12C[C@@H]3Cl,,0
810,CMNPD811,Oc1cc(O)c(Br)c(O)c1,,0
588,CMNPD589,C=C/C=C/C=C\C/C=C\CC,,0
6942,CMNPD6943,C=C(C)C(C)CC[C@@H](C)[C@H]1CCC2C3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)C[C@]4(C)C3CC[C@@]21C,inhibit HIV in vitro,1
755,CMNPD756,CC1(C)[C@@H](Br)CC[C@]2(C)O[C@H]3COC(=O)C3=C[C@@H](O)[C@@H]12,,0
309,CMNPD310,C=CC(C)(CCC=C(C)C)c1ccc2c3c(c[nH]c13)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C,,0
12742,CMNPD12743,CC1=CC[C@]2(C)C[C@H](O)[C@]3(C)C(=O)C=C(C(C)C)[C@@H]3[C@H]2CC1,cytotoxic and anti-HIV–1 activity,1
14351,CMNPD14352,C/C(=C\CC/C(C)=C/CCc1ccoc1)C/C=C/C1=CCC(=O)OC1,potent HIV-1 reverse transcriptase inhibitory activity,1
6716,CMNPD6717,C/C(=C\CCc1ccoc1)CCC(=O)N[C@H](CCOP(=O)(O)OCCCCC(C)C)C(=O)O,mild anti-HIV activity,1
150,CMNPD151,C/C(=C\Cc1occc1C)Cc1cc(C)co1,,0
31546,CMNPD31547,COC(=O)C(O)[C@H]1[C@]2(C)C[C@@]3(O)[C@]1(C)[C@H]1CC[C@]4(C)C(=C1C(=O)[C@@]3(O)C2)CC(=O)O[C@H]4c1ccoc1,Anti-HIV-1 activ. | weakly cytotox.,1
21,CMNPD22,C#C/C=C/C[C@@H](OC(C)=O)[C@H]1C/C=C\C[C@H](Br)[C@@H](CC)O1,,0
497,CMNPD498,CC(C)=CCC[C@@H]1C(=O)O[C@H]2OC(=O)/C3=C/C/C=C(\C)CC[C@H]1[C@H]32,,0
356,CMNPD357,C=C1CCCC(C)(C)C1CC/C(C=O)=C\C=O,,0
12760,CMNPD12761,CC(C)C1=C[C@H](O)[C@@]2(C)CC[C@@]3(C)C=C[C@@](C)(O)CC[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
491,CMNPD492,CC(C)=CCC[C@H](C)[C@@H]1CC/C(C)=C/C/C=C2/C(=O)OC[C@@H]21,,0
29894,CMNPD29895,COC(=O)C[C@H]1C(C)(C)[C@H](OC(C)=O)[C@H]2C(=O)[C@]1(C)[C@H]1CC[C@]3(C)C(=CC(=O)O[C@H]3c3ccoc3)[C@]13O[C@H]23,mod AV (HIV-1).,1
354,CMNPD355,C=C1CCCC(C)(C)[C@@H]1CCC(/C=C/OC(C)=O)=C\OC(C)=O,,0
234,CMNPD235,COc1cc(C)c(O)c(C[C@@H]2[C@H]3CCC(=C(C)C)[C@@H](CCC(=O)O)[C@@H]3CC[C@H]2C)c1,,0
551,CMNPD552,CC(=O)O[C@H]1C[C@@H](/C(C)=C\CC=C(C)C)[C@@H]([C@H]2C(=O)C[C@H](O)[C@H]2C)[C@@H]1C=O,,0
253,CMNPD254,COc1c(Br)cc2cc[nH]c2c1Br,,0
543,CMNPD544,CC(=O)O[C@]12CC[C@@H](C)[C@H]1[C@@H]1[C@H](/C(C)=C\CC=C(C)C)C[C@H](O)[C@@]12C,,0
161,CMNPD162,CC(=O)O[C@H]1C[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]2(C)[C@@H]2CC=C(C=O)[C@H](C=O)[C@@]12C,,0
13176,CMNPD13177,O=c1cc(-c2ccc(O)cc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3OS(=O)(=O)O)cc(O)c12,HIV integrase inhibitor,1
20207,CMNPD20208,O=C1C(c2ccc(O)c(OS(=O)(=O)O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(O)c2)C(=O)c2cc(O)c(OS(=O)(=O)O)cc2-3)-c2cc(O)c(O)cc21,anti-HIV active,1
140,CMNPD141,C=C1C(=O)O[C@H]2[C@H]3O[C@@H](C[C@@H]12)[C@](C)(O)CC/C=C(\C)CCC[C@H]3C,cytotoxicity,0
25006,CMNPD25007,CC(=O)O[C@H]1C/C=C(\C)CC[C@@H]([C@H](C)CCC=C(C)C)[C@@H](O)/C=C/1C,"evaluated against HIV-1, H5N1and LPS-induced NO production",1
764,CMNPD765,CC(C)=C1CC[C@@]2(C)CCCC(C)=C2C1,,0
661,CMNPD662,C[C@]1(/C=C/Cl)C[C@](Cl)(CBr)[C@@H](Cl)C[C@H]1Cl,,0
476,CMNPD477,CC1=CCC23[C@@H]([C@@H]12)[C@H](C(C)C)CC[C@H]3C,,0
26451,CMNPD26452,CC(C)=CCC[C@@H](C)[C@H]1[C@H]2/C(=C\C/C=C(\C)C[C@H]1O)CO[C@@H]2O,weakly active against wild-type HIV-1,1
209,CMNPD210,CC1=CC2=C(C(C)C)CC[C@H](C)C2CC1,,0
339,CMNPD340,COc1cc(Br)c(-c2c(Br)[nH]c3ccc(Br)cc23)c2c(Br)c[nH]c12,,0
30661,CMNPD30662,COc1c(O)cc2c(=O)c3c(oc2c1C(=O)O)CC(C)(O)OC3,No activation latent HIV. | No inhib. bromodomain-containing protein (BRD4).,1
397,CMNPD398,CCCCCCCCCCCCCCCc1cc(=O)c2c(O)cc(O)cc2o1,,0
5408,CMNPD5409,O=C(O)CCCC#CC#C/C=C/CCCCCC/C=C/Br,inhibit the activity of HIV-1 protease,1
204,CMNPD205,[C-]#[N+][C@@H]1[C@H]2[C@H](C)CCC[C@]2(C)CC[C@H]1C(=C)C,,0
602,CMNPD603,C#C/C=C/C/C=C\C/C=C\C/C=C\CC,,0
231,CMNPD232,C/C(=C\CC[C@]1(C)CCc2cc(O)cc(C)c2O1)CC/C=C(\C)CCC1OC1(C)C,,0
30948,CMNPD30949,C[C@@H]1Cc2oc3cccc(O)c3c(=O)c2[C@@H](CO)[C@H]1O,IA vs. 8 HTCLs | NT vs. HIV-1.,1
612,CMNPD613,C#C/C=C\CC1O/C(=C(\Br)CC)C[C@H]2O[C@H]2C[C@H]1Cl,,0
160,CMNPD161,CC(=O)O[C@H]1C[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]2(C)[C@@H]2CC=C3CO[C@@H](O)[C@@H]3[C@@]12C,,0
583,CMNPD584,C=C[C@@H]1CC=C[C@@H]1/C=C\CC,,0
401,CMNPD402,CCCCC/C=C\C/C=C\C/C=C\CCCCc1cc(O)cc(O)c1,,0
279,CMNPD280,Nc1ncc(/C=C/CNC(=O)c2cc(Br)c(Br)[nH]2)[nH]1,,0
768,CMNPD769,CC(=O)O[C@@H]1C[C@]2(C)[C@@H](Br)CC[C@@](C)(O)[C@H]2[C@@H]1[C@@H](O)[C@@]1(O)CC[C@H](Br)C(C)(C)C1,,0
222,CMNPD223,CC(C)=CCC[C@H](C)[C@@H]1CC/C(C)=C/CC/C=C/[C@@H]1O,,0
10566,CMNPD10567,CO[PH](=O)O[C@H]1C2C3C(CC[C@]2(C)C2[C@H](C)C[C@H]([C@@H](C)C(C)C)O[C@@H]21)[C@@]1(C)CC[C@@H](OS(=O)(=O)O)[C@H](O)C1[C@H](O)[C@@H]3O[PH](=O)O,inhibitor of HIV-1 integrase,1
10829,CMNPD10830,COc1ccc(-c2c3c4cc(OC)c(OS(=O)(=O)O)cc4oc(=O)c3n3ccc4cc(OC)c(OC)cc4c23)cc1O,inhibitor of HIV-1 integrase,1
500,CMNPD501,CC(C)=CCC[C@H](C)[C@H]1CC/C(C)=C\CCc2cocc21,,0
8180,CMNPD8181,COC(c1ccc(O)cc1)[C@@H]1NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](C(C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](O)[C@H](O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)[C@H](O)[C@@H](C)CC(C)C)[C@@H](C)[C@@H](C)C(N)=O)[C@@H](C)OC(=O)[C@H](C)N(C)C1=O,protect cells infected with HIV | significant cytotoxicity,1
26242,CMNPD26243,C=C(C)C=C=C1C[C@@H]2O[C@@H](C(C)(C)O)C[C@]23O[C@@H]3[C@@H]1O,"inactive, IA vs. H1N1 and HIV.",1
6856,CMNPD6857,CCc1c(C)c2c(c(C)c1C1=C/C(=C3/C=C(c4c(C)c5c(c(C)c4CC)[C@](C)(O)C[C@@H]5C)NC3=O)C(=O)N1)[C@H](C)C[C@]2(C)O,inhibitor of HIV- 1,1
6269,CMNPD6270,CC(C)C1(CC[C@@H](C)[C@H]2CC[C@@]3(C)C4C[C@H](OS(=O)(=O)O)[C@H]5C[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)C[C@]5(C)C4=CC[C@]23C)CC1C,cytoprotective against HIV-1 in the NCI primary screen,1
133,CMNPD134,CC(=O)CC[C@@H]1OC(=O)CC1(C)C,,0
569,CMNPD570,C=C1CC[C@@H](O)[C@@]2(C)CC=C3[C@](C)(CC[C@]3(O)C(C)C)C[C@]12O,,0
358,CMNPD359,CC(=O)OC/C=C(/C=O)CCC1C(C)=CCCC1(C)C,,0
195,CMNPD196,[C-]#[N+]C(C(C)C)C1CCC2(C)CCCC(=C)C12,,0
597,CMNPD598,CCCCC1=C(Br)/C(=C/Br)OC1=O,,0
4941,CMNPD4942,CC(=O)Oc1c(O)ccc(O)c1C[C@]1(C)[C@@H](C)CC[C@]2(C)C(C)=CCC[C@@H]12,cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities,1
435,CMNPD436,CC(C)=CCC/C(C)=C/C(O)C(O)/C(C)=C/CC[C@]1(C)CCc2cc(O)cc(C)c2O1,,0
159,CMNPD160,CC(=O)O[C@H]1C[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]2(C)[C@@H]2CC=C3C(=O)O[C@@H](O)[C@@H]3[C@@]12C,,0
312,CMNPD313,COCC1(O)C/C(=C\C(=O)N2CC(OC)=CC2=O)N(C)C1=O,,0
420,CMNPD421,CC(C)=CCC/C(C)=C/C(O)C(O)/C(C)=C/CC/C(C)=C/CC1=CC(=O)C(C)=C(C)C1=O,,0
122,CMNPD123,C/C(=C/CO)CC[C@H]1[C@]2(C)CC[C@@H](Br)C(C)(C)[C@H]2CC[C@@]1(C)O,,0
540,CMNPD541,CC(C)=CC/C=C(/C)[C@@H]1CC[C@@]2(C=O)[C@@H]1[C@@H]1[C@H](C)CC[C@@]12O,,0
95,CMNPD96,CC1(Cl)CC2OC3(Br)[C@H](O)[C@H]4O[C@@]4(C)C2(CC1Br)C3(C)C,,0
104,CMNPD105,CC1=CCC(Br)C(C)(C)C12CCC1(C)OC1C2,,0
55,CMNPD56,C=C[C@@](C)(Cl)[C@@H](Cl)/C=C/C(C=O)=C\Cl,,0
761,CMNPD762,C[C@H]1CCC[C@]2(C)CC[C@@]3(C(C)(C)O)C[C@@]123,,0
249,CMNPD250,Oc1c(Br)cc(Oc2c(O)c(Br)c(Oc3cc(Br)c(O)c(Br)c3Br)c(O)c2Br)c(Br)c1Br,,0
706,CMNPD707,CC1=CC[C@@]2(CC1)C(C)=CC[C@@H](Br)C2(C)C,,0
12042,CMNPD12043,CC[C@@]1(C)CCC[C@@]2(C)C1CC[C@]1(C)C2C[C@H](O)[C@]2(C)C3=C(CCC12)[C@@](C)(O)OC3=O,inhibitor of in vitro HIV-1 envelope-mediated fusion,1
454,CMNPD455,CC(C)=CC(=O)C/C(C)=C/CC1OC1(C)/C=C/C/C(C)=C/CO,,0
545,CMNPD546,CC(=O)O[C@@H]1C[C@@H](/C(C)=C\CC=C(C)C)[C@@H]([C@H]2C(=O)C=C[C@H]2C)[C@@H]1C=O,,0
301,CMNPD302,N=C1N[C@H]2[C@H](COC(=O)NS(=O)(=O)O)NC(=N)N3C[C@@H](OS(=O)(=O)O)C(O)(O)[C@]23N1,toxin,0
457,CMNPD458,CC(=O)CC/C=C(\C)CCC/C(C)=C\C(=O)CC(C)C,,0
472,CMNPD473,C=C(C)[C@@H](O)CC/C(C)=C/CC/C(C)=C/CCC(C)=O,,0
190,CMNPD191,C=C1CCC2C(C)(C)CCC[C@@]2(C)[C@]1(C)Cc1cc(O)ccc1O,,0
776,CMNPD777,CC(=O)O[C@]1(C[C@@H]2CC[C@]3(CO)[C@@H](Br)CC[C@@](C)(O)[C@@H]23)CC[C@H](Br)C(C)(C)C1,,0
111,CMNPD112,C=CC(C)(O)CCC1C(=C)CC[C@H](Br)C1(C)C,,0
451,CMNPD452,CC(C)=CC(=O)C/C(C)=C/CC/C(C)=C/CC/C(C)=C/CO,,0
385,CMNPD386,C=C1CC[C@@H](Br)C(C)(C)C1Cc1cc(O)c(Br)cc1O,,0
10565,CMNPD10566,CO[PH](=O)O[C@H]1C2C3C(CC[C@]2(C)C2[C@H](C)C[C@H]([C@@H](C)C(C)C)O[C@@H]21)[C@@]1(C)CC[C@@H](OS(=O)(=O)O)[C@H](O)C1[C@H](O)[C@@H]3O,inhibitor of HIV-1 integrase,1
225,CMNPD226,C/C1=C\CC[C@@H](C)/C=C/[C@@]2(C)CC[C@@H](C(C)(C)O)[C@@H]2[C@@H](O)C1,,0
633,CMNPD634,C#C/C=C/C[C@@H]1O[C@@H]1C[C@H](Br)[C@H]1C[C@H](Br)[C@@H](CC)O1,,0
19738,CMNPD19739,C[C@@]1(C(=O)O)[C@@H](O)CC[C@]2(C)c3cc4c(cc3CC[C@@H]12)[nH]c1ccccc14,activity in a panel of cytotoxicity assays | selective anti-HIV activity | specifically blocking the R5 strain but having no effect on the X4 tropic HIV-1 strain,1
704,CMNPD705,C=C1CC[C@@](C)(c2ccc(COC(C)=O)cc2)[C@H]1C,,0
380,CMNPD381,CCCCCCCCCCCCCCCCCC(=O)NC(CO)C(O)CCCCCCCCCCCCCCC,,0
639,CMNPD640,C#C/C=C\C[C@H]1O[C@@H](C(Br)C/C=C/CC)C[C@H]1OC(C)=O,,0
698,CMNPD699,Cc1cc2c(cc1Br)C1(C)CCC(CBr)(O2)C1C,,0
352,CMNPD353,CCCCCC/C=C/CCCCCCCC(=O)OCC/C(=C/OC(C)=O)C(C/C=C(\C)C#CC=C(C)C)OC(C)=O,,0
432,CMNPD433,COc1cc(C)c(O)c(C/C=C(\C)CC(O)/C=C(\C)CCCC(C)C(=O)C(O)C=C(C)C)c1,,0
332,CMNPD333,CO[C@@H](CC[C@H](C)C1O[C@@]23C[C@H](OC(=O)C[C@H]([C@@H](C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C)c1cc(O)c(Br)cc1Br,toxic,0
732,CMNPD733,C=C(C)[C@H]1C[C@@]23[C@@H](O1)O[C@]2(C)[C@@H](O)C=C(Br)C3(C)C,,0
242,CMNPD243,Oc1c(Br)cc(Br)cc1Br,,0
337,CMNPD338,C=CC[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](CCCCC)OC)OC)OC)OC)OC)OC)OC)OC)OC)OC,,0
791,CMNPD792,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@H]1O[C@]1(C)CC/C=C(\C)CCC=C(C)C,,0
13174,CMNPD13175,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3OS(=O)(=O)O)cc(O)c12,HIV integrase inhibitor,1
317,CMNPD318,CCCC(=O)N[C@H]1CCOC1=O,,0
742,CMNPD743,CC1(C)C(Br)[C@@H](O)C=C2C[C@]3(C)CC[C@@]21CC3Cl,,0
384,CMNPD385,CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(O)CCCCCCCCCCCCCCC,,0
412,CMNPD413,CCCCc1cc(C)c(CCCCCCCCC(=O)O)o1,,0
25005,CMNPD25006,CC(C)=CCC[C@](C)(O)[C@@H]1CC=C(C)[C@@H]2CC=C(C)[C@H]2[C@@H]1O,"evaluated against HIV-1, H5N1and LPS-induced NO production",1
164,CMNPD165,CC1=C(O)/C(=C/[C@@H](C)CCC[C@H](C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O,,0
381,CMNPD382,CCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(O)CCCCCCCCCCCCCCC,,0
10422,CMNPD10423,CCC(C)/C=C(C)/C=C\C(O)C(C)(O)C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1C(=O)N[C@H](COC)C(=O)NCC(=O)N[C@@H](C)C(=O)NC([C@@H](C)O)C(=O)NC(C(OC)c2ccc(O)cc2)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]1C(C)C)[C@@H](C)[C@@H](C)C(N)=O)[C@H](C)N)[C@@H](C)O,cytotoxic | HIV-inhibitory,1
50,CMNPD51,C[C@@](Cl)(/C=C/Br)[C@@H](Cl)/C=C/C(=C\Cl)C(Cl)Cl,,0
719,CMNPD720,C=C1CC[C@@H](Br)C(C)(C)[C@]12CC[C@](C)(Br)[C@@H](Cl)C2,,0
39,CMNPD40,CC(C)(Cl)[C@H](Br)CC1O[C@]1(C)/C=C/Br,,0
370,CMNPD371,CC(C)=CC(=O)C[C@@H](C)[C@H]1CC[C@@]2(C)C3CC[C@H]4C(C)=CCC[C@@]45C[C@@]35CC[C@]12C,ichthyotoxicity,0
126,CMNPD127,CC(C)[C@@H]1CC=C[C@H]2[C@H]3[C@](C)(CC[C@]12CBr)[C@@H](Br)CC[C@@]3(C)O,,0
4939,CMNPD4940,CC1=CCC[C@@H]2C1CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(O)C1=O,cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities,1
214,CMNPD215,CC(C)=CCC/C(C)=C/C(O)C/C(C)=C/CC/C(C)=C/CO,,0
208,CMNPD209,[C-]#[N+]C1CC2C3CC1(C)CC2(C)C[C@H]3C(C)C,,0
789,CMNPD790,Cc1ccc2c(c1)[C@H]1CC[C@H](C(C)C)[C@]1(C)CCC2C,,0
311,CMNPD312,COC1=CC(=O)N(C(=O)/C=C2/C=C(CO)C(=O)N2C)C1,,0
266,CMNPD267,COC1(N=[N+]=[N-])C(Br)=CC(O)(CC(N)=O)C=C1Br,,0
641,CMNPD642,C#C/C=C\C[C@H]1O[C@@H](C(Br)C/C=C/CC)C[C@H]1O,,0
499,CMNPD500,CC(C)=CCC[C@H](C)[C@H]1CC/C(C)=C/CCc2cocc21,,0
9727,CMNPD9728,C=C1[C@@H](c2cc(O)ccc2O)C2=C(CC[C@H]1C)C(C)(C)CCC2,inhibit HIV-1 in the NCI primary screen,1
78,CMNPD79,C=C(C)/C(=C/Br)CCC=C(C)C,,0
640,CMNPD641,C#C/C=C/C[C@H]1O[C@@H](C(Br)C/C=C/CC)C[C@H]1O,,0
5405,CMNPD5406,O=C(O)CCCC#C/C=C/CCCC/C=C/C#C/C=C/Br,inhibit the activity of HIV-1 protease,1
12753,CMNPD12754,CC(C)C1=CC(=O)[C@@]2(C)CC[C@@]3(C)C[C@@H](O)[C@]4(C)O[C@@H]4C[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
329,CMNPD330,CO[C@@H](CC[C@H](C)C1O[C@@]23C[C@H](OC(=O)C[C@H](CO)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C)c1cccc(O)c1,toxic,0
424,CMNPD425,CC(C)=CCC[C@@](C)(O)[C@@H](O)CC/C(C)=C/CC/C(C)=C/Cc1cc(O)cc(C)c1O,,0
313,CMNPD314,COC1=CC(=O)N(C(=O)/C=C2\CC(O)(CO)C(=O)N2C)C1,,0
652,CMNPD653,C[C@@](Cl)(/C=C/Br)[C@@H](Cl)/C=C/C(Cl)(CCl)CBr,antifungal | molluscicidal activities | toxicity to brine shrimp,0
12759,CMNPD12760,CC(C)C1=C[C@H](O)[C@@]2(C)C(=O)C[C@@]3(C)C=C[C@@](C)(O)CC[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
646,CMNPD647,C#C[C@@H](Br)[C@H]1C[C@H]2O[C@]3(C[C@H]2O1)OC([C@H](Br)CC)C[C@@H]3Br,,0
769,CMNPD770,CC1(C)C[C@@](O)([C@H](O)[C@@H]2CC[C@]3(C)[C@@H](Br)CC[C@@](C)(O)[C@@H]23)CC[C@@H]1Br,,0
137,CMNPD138,C=C1C(=O)O[C@]2(C)CC[C@@H]1C[C@@H]1O[C@@]1(C)CC/C=C(\C)CC[C@@H]2O,,0
414,CMNPD415,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=CC(=O)C=C(C)C1=O,,0
37,CMNPD38,C#C/C=C\[C@H](Cl)C(O)[C@@H]1C[C@@H]2O[C@@H]2C[C@@H](Br)[C@H](CC)O1,,0
30,CMNPD31,C#C/C=C\C[C@H]1OO/C(=C(/Br)CC)C/C=C\C[C@H]1Cl,,0
211,CMNPD212,C=C(C)C1CC[C@@]2(C)[C@H](O)CC=C(C)[C@@H]2C1,,0
579,CMNPD580,C=C1C[C@@H]2OC(C)(C)[C@@H]3CC[C@](C)(C[C@H]4[C@H](C)CC[C@@H]14)[C@@H]23,,0
67,CMNPD68,CC1=C(/C=C/Cl)C[C@H](Br)[C@](C)(Cl)C1,,0
123,CMNPD124,C=C[C@](C)(O)CC[C@]1(O)[C@@H](C)CC[C@@H]2C(C)(C)[C@H](Br)CC[C@]21C,,0
70,CMNPD71,C=C1C[C@](C)(Cl)[C@H](Br)C[C@@H]1/C=C/Cl,,0
218,CMNPD219,CC(C)=CCC[C@@H](C)[C@@H]1CC=C2CO[C@@H]3C=C(C)[C@@H]([C@@H]1O)[C@H]23,,0
236,CMNPD237,Oc1c(Br)cc(Br)cc1-c1[nH]c(Br)c(Br)c1Br,antibiotic | cytotoxic | antimicrobial,0
12041,CMNPD12042,CCC(=O)O[C@@H]1CC[C@]2(C)C3C[C@H](OC(C)=O)[C@]4(C)C5=C(CCC4[C@]3(C)CCC2[C@@]1(C)CC)[C@H](C)OC5=O,inhibitor of in vitro HIV-1 envelope-mediated fusion,1
245,CMNPD246,OCc1cc(Br)c(O)c(Cc2cc(Br)c(O)c(Br)c2)c1,,0
425,CMNPD426,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/Cc1cc(O)cc(C)c1O,,0
493,CMNPD494,CC(=O)OC[C@H]1/C(C=O)=C\C/C=C(\C)CC[C@@H]1[C@@H](C)CCC=C(C)C,,0
734,CMNPD735,C=C(C)[C@H]1C[C@@]23[C@@H](O1)O[C@]2(C)[C@@H](Br)C=C(Br)C3(C)C,,0
215,CMNPD216,C/C(=C\CO)CCC[C@H](C)CCC[C@H](C)CCCC(C)C,,0
605,CMNPD606,C#C/C=C\C[C@H]1O/C(=C(/Br)CC)C[C@H]2O[C@H]2C[C@H]1Cl,,0
76,CMNPD77,CO[C@@]1(C(Br)Br)O[C@H](/C(C)=C\Cl)CC(Cl)=C1C,,0
5,CMNPD6,O=S1(=O)CSCSSC1,antibiotic,0
265,CMNPD266,CCOC1(OC)C(Br)=CC(O)(CC(N)=O)C=C1Br,,0
16,CMNPD17,CCCCC1(Br)OC1C(Br)Br,,0
25003,CMNPD25004,CC(=O)O[C@H]1[C@H]2C(C)=CC=C[C@@]2(C)C(=O)C[C@@H]2[C@]1(C)CC[C@@]2(O)C(C)C,"evaluated against HIV-1, H5N1and LPS-induced NO production",1
573,CMNPD574,C=C1CC[C@@H](O)[C@@]2(C)C[C@@H](OC(C)=O)C3=C(C(C)C)[C@@H](OC(C)=O)C[C@]3(C)C[C@]12O,,0
13498,CMNPD13499,CCCCCCCCCCCc1nc(=N)n2c(c1C(=O)OCCCCNC(=N)N)CCC2,weak inhibitor of HIV-1 envelope-mediated fusion,1
121,CMNPD122,CC1(C)C/C(=C/[C@@H]2[C@H](O)C[C@]3(C)[C@@H](Br)CC[C@@](C)(O)[C@@H]23)CC[C@@H]1Br,,0
156,CMNPD157,CC1CCCC(C)(C)/C1=C/Cc1ccoc1,,0
342,CMNPD343,COc1cc(Br)c(-n2cc(Br)c3cc(Br)ccc32)c2c(Br)c[nH]c12,,0
804,CMNPD805,CCC1=CC/C=C\C/C=C\CC#CCCCCc2cc(=O)cc(o2)O1,,0
12754,CMNPD12755,CC(C)C1=CC(=O)[C@@]2(C)CC[C@@]3(C)CC(=O)[C@]4(C)O[C@@H]4C[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
141,CMNPD142,C=C1C(=O)O[C@H]2[C@H]3O[C@@](C)(CC/C=C(\C)CCC[C@H]3C)[C@@H](O)C[C@@H]12,cytotoxicity,0
180,CMNPD181,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=CC(O)C=CC1O,,0
118,CMNPD119,C=C1CCC(C(C)C)/C=C/[C@](C)(O)CCC1O,,0
24819,CMNPD24820,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc2c(c1O)CNC2=O,mod. inhib. of HIV-1,1
257,CMNPD258,O=S(=O)(O)OCc1cc(O)c(OS(=O)(=O)O)c(Br)c1Br,,0
536,CMNPD537,C=C(C(O)/C=C/[C@@](C)(O)CO)[C@@H]1CC(=O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
20213,CMNPD20214,O=C(O)Cn1c2c(c3c1=C(c1ccc(O)c(O)c1)C(=O)c1cc(O)c(OS(=O)(=O)O)cc1-3)-c1cc(O)c(O)cc1C(=O)C=2c1ccc(O)c(O)c1,anti-HIV active,1
489,CMNPD490,C=C1CC[C@@H](C(C)CCC=C(C)C)[C@@H](O)[C@@H]2C(C)=CC[C@@H]12,,0
762,CMNPD763,CC(=O)O[C@H]1[C@@H](C(C)C)CC[C@@]2(C)[C@H](Br)CC[C@@](C)(O)[C@H]12,,0
244,CMNPD245,O=C1C(Br)=CC2(C=C1Br)Cc1cc(CO)cc(Br)c1O2,antifungal,0
18789,CMNPD18790,CC1=CC(=O)C=C[C@]2(C)[C@H]3[C@@H](O)C=C(C)[C@@]4(Cc5c(c(C)c(C)oc5=O)O4)[C@]3(C)CC[C@@H]12,moderate inhibitor of HeLa cells | inhibit HIV-1 replication in C8166 cells,1
820,CMNPD821,O=C(O)Cc1c(Br)c(O)cc(O)c1Br,,0
462,CMNPD463,CC(=O)CC/C=C(\C)CCC/C(C)=C/C(=O)CC(C)C,,0
388,CMNPD389,CC(=O)Oc1cc(OC(C)=O)c(Oc2cc(OC(C)=O)c(Oc3cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c3Oc3cc(OC(C)=O)c(Oc4cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c4Oc4cc(OC(C)=O)c(Oc5cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c5Oc5cc(OC(C)=O)c(Oc6cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c6Oc6cc(OC(C)=O)c(Oc7cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c7)c(OC(C)=O)c6)c(OC(C)=O)c5)c(OC(C)=O)c4)c(OC(C)=O)c3)c(OC(C)=O)c2)c(OC(C)=O)c1,,0
239,CMNPD240,CC1=CC(=O)CC2(O)C3=C(C=CC12O)C(=O)c1c(O)cccc1C3=O,antibiotic,0
330,CMNPD331,CO[C@@H](CC[C@H](C)C1O[C@@]23C[C@H](OC(=O)C[C@H](CO)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C)c1cc(O)ccc1Br,toxic,0
808,CMNPD809,CO[C@]1(Cc2ccc(O)cc2)C(=O)OC2[C@@H](O)CO[C@@]21O,,0
100,CMNPD101,C=C1C[C@H](O)[C@@H](Br)C(C)(C)[C@@]12CC[C@@](C)(Br)[C@H](Cl)C2,,0
347,CMNPD348,CC(/C=C/C=C(\C=O)CC=O)=C\C=C\C(C)(C)O,toxic,0
792,CMNPD793,CC(C)CC[C@H](O)[C@](C)(O)C1CCC2C3=CC(=O)C4=C[C@H](O)[C@@H](O)C[C@]4(C)C3CC[C@@]21C,ecdysone,0
705,CMNPD706,C=C1CC[C@@](C)(c2ccc(C=O)cc2)[C@H]1C,,0
30946,CMNPD30947,C[C@]12C[C@H](O)[C@]3(O)C(=O)c4c(O)cccc4O[C@@]3(CO1)[C@@H]2O,IA vs. 8 HTCLs and HIV-1.,1
11184,CMNPD11185,CC(C)CCCCCCCCCCCCC(=O)NCCCOc1c(Br)cc(CCNC(=O)CCCCCCCCCCCCC(C)C)cc1Br,inhibit HIV-1,1
672,CMNPD673,CC1(C)[C@@H](Br)C[C@H]2OC(=O)C=C2[C@@H]1Cl,,0
751,CMNPD752,CC1(C)[C@@H](Br)CC[C@]2(C)O[C@H]3COCC3=CC[C@@H]12,,0
20211,CMNPD20212,O=C1C(c2ccc(O)c(O)c2)=C2C(=C(c3ccc(O)c(O)c3)C(=O)N2CCc2ccc(OS(=O)(=O)O)cc2)c2cc(O)c(O)cc21,anti-HIV active,1
666,CMNPD667,C[C@]1(/C=C/Cl)CC(CCl)=CC[C@H]1Cl,,0
20215,CMNPD20216,O=c1oc2cc(O)c(O)cc2c2c1[nH]c1c(=O)oc3cc(O)c(OS(=O)(=O)O)cc3c12,anti-HIV active,1
817,CMNPD818,COc1cc(Cc2c(OC)c(Br)c(OC)c(Br)c2OC)c(Br)c(Br)c1OC,,0
201,CMNPD202,C[C@@H]1CC[C@@H]2[C@@H]1[C@H]1[C@@H](CCC2(C)N=C=S)C1(C)C,,0
806,CMNPD807,CCC1Oc2oc(cc(=O)c2Br)CCCCC#CC/C=C\C/C=C\CC1Br,,0
12745,CMNPD12746,CC(C)C1=CC(=O)[C@@]2(C)CC[C@@]3(C)C[C@H]4O[C@@]4(C)CC[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
594,CMNPD595,CCCCCC(=O)C(I)=C(Br)Br,,0
725,CMNPD726,C=C1CCC2OC3C[C@](C)(Cl)[C@@H](Br)CC13C2(C)C,,0
721,CMNPD722,C=C1C[C@@H](O)[C@@H](Br)C(C)(C)[C@@]12C=C/C(=C\Br)CC2,,0
2,CMNPD3,[O-][S+]1CSCS1,antibiotic,0
756,CMNPD757,CC(=O)O[C@@H]1C=C2C(=O)OC[C@@H]2O[C@@]2(C)CC[C@H](Br)C(C)(C)[C@H]12,,0
785,CMNPD786,CC1=C2[C@@H]3C=CC[C@@H](C(C)C)[C@@]3(CBr)CC[C@]2(C)[C@@H](Br)CC1,,0
394,CMNPD395,CC/C=C\C/C=C\C=C\[C@H](O)C/C=C\CCCCC(=O)c1c(O)cc(O)cc1O,,0
812,CMNPD813,Oc1cc(O)c(Br)c(O)c1Cl,,0
134,CMNPD135,C/C1=C\CC/C(C)=C/[C@H](O)C(C(C)(C)O)CC/C(C)=C/CC1,,0
333,CMNPD334,COc1cc2c([nH]c3ccccc32)c(-c2ccccc2)c1C,,0
710,CMNPD711,CC1=CC[C@@H](Br)C(C)(C)[C@]12CC[C@]1(C)O[C@@H]1C2,,0
197,CMNPD198,C=C1CCC[C@]2(C)CC[C@@H](CC(C)C)[C@H]12,,0
191,CMNPD192,CC1=CCC2C(C)(C)CCC[C@@]2(C)[C@@H]1Cc1cc(O)ccc1O,,0
99,CMNPD100,C=C1C[C@@H](O)[C@H](Br)C(C)(C)[C@]12CC[C@](C)(Cl)[C@@H](Br)C2,,0
19079,CMNPD19080,CCC[C@@H](C)[C@@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](COP(=O)(O)O)NC(=O)[C@H]([C@H](C)C(N)=O)NC(=O)[C@@H]([C@H](C)OC(N)=O)NC(=O)[C@H](O)CNC(=O)/C=C/C=C/C[C@H](O)[C@H]1C,inibited HIV-1 proliferation,1
5407,CMNPD5408,O=C(O)CCCC#CC#C/C=C/CCCC/C=C/Br,inhibit the activity of HIV-1 protease,1
28830,CMNPD28831,CS[C@@]1(Cc2ccccc2)NC(=O)[C@@](Cc2ccccc2O)(SC)NC1=O,signif. AV vs 1 strain and reactivation latent HIV-1 | no cytotox. to norm. hum. cell line,1
155,CMNPD156,CC1=CCC[C@@H](C)[C@@]1(C)CCc1ccoc1,,0
182,CMNPD183,C/C(=C\Cc1cc(O)ccc1O)CCc1c(C)cc(O)c(C=O)c1C,,0
759,CMNPD760,CC(C)[C@@]1(Cl)CC[C@]2(C)[C@@H](Br)CC[C@@](C)(O)[C@H]2C1,,0
119,CMNPD120,CC(=O)[C@H]1CC[C@@H]2[C@@H]1[C@H](C(C)C)CC[C@@]2(C)O,,0
657,CMNPD658,C=C(C)C(=O)/C=C(\Cl)C(C)(Cl)C(Br)CCl,,0
624,CMNPD625,C#C/C=C\[C@H](Cl)[C@@H](O)[C@H]1C/C=C(/Cl)C[C@H](Br)[C@@H](CC)O1,,0
46,CMNPD47,CC(/C=C/[C@H](Cl)[C@](C)(Cl)/C=C/Br)=C(Br)Br,,0
304,CMNPD305,C=C(C=O)C[C@@H]1C[C@H](O)[C@]2(C)O[C@@H]3C[C@@H]4O[C@@H]5C[C@]6(C)O[C@]7(C)CC[C@@H]8O[C@@H]9C[C@]%10(C)O[C@@H]%11C(C)=CC(=O)O[C@H]%11C[C@H]%10O[C@H]9C[C@@H](C)[C@H]8O[C@H]7C[C@H]6O[C@@]5(C)C/C=C\[C@H]4O[C@H]3C[C@H]2O1,toxin,0
12,CMNPD13,CC(Br)C=C(Br)Br,,0
508,CMNPD509,C=C1CC[C@H]([C@@H](C)CCC=C(C)C)[C@H]2C(C=O)=CC[C@@H]1C2O,,0
61,CMNPD62,O=C[C@@H]1C[C@@](Br)(CCl)[C@H](Cl)C[C@@H]1Cl,,0
29817,CMNPD29818,O=C(NCCc1ccccc1)NCCc1ccccc1C(=O)NCCc1ccccc1C(=O)NCCc1ccccc1,weak anti-HIV | no AB activ.,1
9507,CMNPD9508,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(COC1O[C@H](CS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCC,potent inhibitor of eukaryotic DNA polymerases and HIV-1 reverse transcriptase type 1,1
4943,CMNPD4944,COC1=CC(=O)C(C[C@@]2(C)[C@@H]3CCC=C(C)C3CC[C@@H]2C)=C(O)C1=O,cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities,1
296,CMNPD297,N=C1N[C@H]2[C@H](COC(N)=O)NC(=N)N3C[C@@H](OS(=O)(=O)O)C(O)(O)[C@]23N1,toxin,0
12751,CMNPD12752,CC(C)C1=CC(=O)[C@@]2(C)C(=O)C[C@@]3(C)C[C@@H](O)[C@]4(C)O[C@@H]4C[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
143,CMNPD144,C=C1C[C@@H]2O[C@@H](C3C2[C@](C)(OC(C)=O)[C@@H](OC(C)=O)C[C@@H]3C(C)C)[C@](C)(OC(C)=O)CC[C@@H]1OC(C)=O,,0
563,CMNPD564,C=C1CCC[C@@]2(C)CC=C3[C@](C)(CC[C@]3(O)C(C)C)C[C@]12O,,0
514,CMNPD515,CC(C)=CCC[C@@H](C)[C@@H]1CC[C@@]2(C)C=COC=C(C)C2[C@@H]1O,,0
556,CMNPD557,C/C1=C\CC[C@H](C)/C=C/[C@]2(C)CC[C@H](C(C)(C)O)[C@H]2[C@H](O)C1,antimicrobial,0
779,CMNPD780,CC1(C)[C@H](Br)CC[C@@](C)(O)[C@@H]1CC[C@]1(C)O[C@](C)([C@H](O)CCl)CC[C@H]1Br,,0
89,CMNPD90,C=C1CC[C@@](C)(c2cc(Br)c(C)cc2O)[C@H]1C,antibiotic,0
811,CMNPD812,Oc1cc(O)c(Cl)c(O)c1,,0
298,CMNPD299,N=C1N[C@H]2[C@H](COC(N)=O)N(O)C(=N)N3C[C@@H](OS(=O)(=O)O)C(O)(O)[C@]23N1,toxin,0
20205,CMNPD20206,O=C1C(c2ccc(O)c(O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(O)c2)C(=O)c2cc(O)c(OS(=O)(=O)O)cc2-3)-c2cc(OS(=O)(=O)O)c(O)cc21,anti-HIV active,1
206,CMNPD207,[C-]#[N+]C(C)(C=C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C,,0
548,CMNPD549,CC(C)=CC/C=C(/C)[C@@H]1CC=C(C=O)[C@@H]1[C@H]1C(=O)C=C[C@H]1C,,0
516,CMNPD517,CC(C)=CCC[C@@H](C)[C@@H]1CC/C(C)=C/C2OC2/C(C)=C/[C@@H]1O,,0
592,CMNPD593,C[As](C)(=O)CCO,,0
30662,CMNPD30663,CC1(O)Cc2oc3cc(O)c(O)cc3c(=O)c2CO1,No activation latent HIV. | No inhib. bromodomain-containing protein (BRD4).,1
14203,CMNPD14204,C1=C(c2nccc3c2[nH]c2ccccc23)[C@@H]2CCN3CCCC/C=C\CC[C@]14O[C@@H]1CCC/C=C\[C@H]5C[C@@]2(C3)[C@H]4N51,potent antiinflammatory | antifungal | anti-HIV-1 agent,1
600,CMNPD601,C=C1C(Br)=C(Br)[C@H](O)[C@H]1O,,0
740,CMNPD741,CC1=C2CC[C@](C)(Cl)[C@@H](Br)C[C@]2(C)[C@@H](C)[C@@H](Br)[C@@H]1O,,0
537,CMNPD538,C=C(C/C=C/C(C)(C)O)[C@@H]1C[C@@H](O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
28513,CMNPD28514,C[C@H]1CC/C(O)=C2/C(=O)O[C@]34C[C@H](C)[C@@](C)(OC3=O)[C@@H](O)[C@@H]4[C@@H]2CC(=O)O1,"No AB vs. 12 strains | No anti-HIV-1 replication activ. (0.016 to 50 μg/mL), however some promotion of viral replication (10 to 50 μg/mL).",1
5406,CMNPD5407,O=C(O)CCCC#CC#C/C=C/CCCCC#C/C=C/Br,inhibit the activity of HIV-1 protease,1
613,CMNPD614,C#C/C=C/C[C@H]1O/C(=C(\Br)CC)C/C=C\C[C@H]1Cl,,0
644,CMNPD645,C/C=C\[C@@H]1C[C@@H]1[C@@H]1OC2=C(Br)C[C@@H](C=C=CBr)O[C@H]21,,0
56,CMNPD57,C=C[C@@](C)(Cl)[C@@H](Cl)/C=C/C(=C\Cl)COC(C)=O,,0
780,CMNPD781,CC(=O)OCC(Br)[C@]1(C)CC=C2[C@H](C1)[C@@H](O)CC1[C@]3(C)C[C@@H]3[C@@H](OC(C)=O)C[C@]21C,,0
8598,CMNPD8599,O=S(=O)(O)O[C@@H]1[C@H](OC[C@H]2O[C@@H](O)[C@@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1OS(=O)(=O)O,in vitro anti-HIV activity,1
12761,CMNPD12762,CC(C)C1=C[C@H](O)[C@]2(C)[C@H]1[C@H]1CC[C@](C)(O)C=C[C@]1(C)C[C@@H]2O,cytotoxic and anti-HIV–1 activity,1
557,CMNPD558,CC(=O)O[C@@H]1C/C(C)=C/CC[C@H](C)/C=C/[C@]2(C)CC[C@H](C(C)(C)O)[C@@H]12,antimicrobial,0
363,CMNPD364,CC(=O)OC=C(COC(C)=O)CC(=O)CC(C)CCC/C(C)=C/CCC(/C=C/OC(C)=O)=C\OC(C)=O,,0
12746,CMNPD12747,C=C1CC[C@@H]2[C@H]3C(C(C)C)=CC(=O)[C@@]3(C)CC[C@@]2(C)C[C@H]1O,cytotoxic and anti-HIV–1 activity,1
645,CMNPD646,C=C(C)C[C@@H]1C[C@@H]1[C@@H]1OC2=C(Br)C[C@@H](C=C=CBr)O[C@H]21,,0
114,CMNPD115,C=CC(C)(O)CCC1=C(C)CC[C@H](Br)C1(C)C,,0
74,CMNPD75,CC(=C/Cl)/C=C/C(Cl)=C(/C)C(=O)C(Br)Br,,0
470,CMNPD471,CC(=O)CC/C=C(\C)CCC1=C(C)CC[C@H](O)C1(C)C,,0
12058,CMNPD12059,C=C(CC[C@@H](C)[C@H]1CC[C@@]2(C)C3C[C@H](OS(=O)(=O)O)C4C[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)C[C@]4(C)C3=CC[C@]12C)C(C)(C)C,inhibitor of HIV-1 integrase,1
535,CMNPD536,C=C(C(O)/C=C/[C@](C)(O)CO)[C@@H]1CC(=O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
259,CMNPD260,Oc1cc(O)c(Br)c(O)c1O,,0
699,CMNPD700,Cc1ccc2c(c1)OC1(C(Br)Br)CCC2(C)C1C,,0
736,CMNPD737,CC1(C)C(C=O)=C[C@]2(C)O[C@@H]3C[C@]12CC[C@]3(C)Cl,,0
196,CMNPD197,C=C1CCC[C@]2(C)CC[C@@H]([C@@H](N=C=S)C(C)C)[C@H]12,,0
463,CMNPD464,C/C(=C/C(=O)CC(C)C)CCC/C(C)=C/CCC(C)O,,0
595,CMNPD596,CCCCC(Cl)C(=O)C(I)=C(Br)Br,,0
737,CMNPD738,C[C@H]1C=C(Br)C(C)(C)[C@]2(CC[C@](C)(Cl)[C@@H](Br)C2)C1=O,,0
107,CMNPD108,CC1=CC[C@@]2(C)C(=C(C)C(=O)[C@@H](Cl)[C@@H]2C)CC1,,0
16838,CMNPD16839,COC(=O)CCC[C@@H]1CC[C@@H](C#C/C=C/CCCC/C=C\C=C/Br)O1,inhibit the growth of the HIV opportunistic fungus Cryptococcus neoformans,1
696,CMNPD697,Cc1ccc2c(c1)O[C@@]1(CO)[C@@H](C)CC[C@@]21C,,0
782,CMNPD783,CC(C)[C@@H]1C=C[C@H](O)[C@H]2[C@H]3[C@](C)(CC[C@@]21CBr)[C@@H](Br)CC[C@@]3(C)O,,0
10564,CMNPD10565,CNS(=O)(=O)O[C@H]1C2C3C(CC[C@]2(C)C2[C@H](C)C[C@H]([C@@H](C)C(C)C)O[C@@H]21)[C@@]1(C)CC[C@@H](OS(=O)(=O)O)[C@H](O)C1[C@H](O)[C@@H]3OS(=O)(=O)O,inhibitor of HIV-1 integrase,1
153,CMNPD154,C=C1OC(O)C=C1CCC1C(=C)C=CCC1(C)C,,0
453,CMNPD454,CC(C)=CC(O)C/C(C)=C/CC/C(C)=C/CC/C(C)=C/CO,,0
232,CMNPD233,Cc1cc(O)cc2c1O[C@@]1(C)CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@@H]1C2,,0
746,CMNPD747,C=CC(C)(O)CC[C@H](Br)[C@@]1(C)CC[C@H](Br)C(C)(C)O1,,0
745,CMNPD746,CC1(C)C[C@@H]([C@@]23CC[C@@](C)(O2)[C@H](Br)C3)CC[C@@H]1Br,,0
105,CMNPD106,C[C@H]1C(=O)[C@@H](Br)[C@H](C)[C@@]2(C)C[C@@H](Br)[C@@]3(C)CC[C@]132,,0
750,CMNPD751,CC1(C)[C@@H](Br)CC[C@]2(C)O[C@H]3COC(=O)C3=CC[C@@H]12,,0
695,CMNPD696,Cc1c(Br)cc([C@]2(C)CC[C@@H]3C[C@@]32C)c(O)c1Br,,0
282,CMNPD283,COc1cc(Br)c(O)cc1C/C=C(\C)CCC=C(C)C,,0
106,CMNPD107,CC1=CC[C@@]2(C)C(=C(C)C(=O)[C@@H](O)[C@@H]2C)CC1,,0
422,CMNPD423,CC(C)=CCC/C(C)=C/C(O)C/C(C)=C/CC/C(C)=C/Cc1cc(O)cc(C)c1O,,0
24,CMNPD25,C#C/C=C/CC1O[C@@H]2C[C@H]1O[C@H](CC)[C@@H](Br)C[C@H]2O,,0
803,CMNPD804,C[C@H]1O[C@H]([C@]2(C)OC=CC2=O)CC1=O,,0
382,CMNPD383,CCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(O)CCCCCCCCCCCCCCC,,0
589,CMNPD590,C[As](C)(=O)C[C@@H]1CC[C@H](OCC(O)CO)O1,,0
400,CMNPD401,CC/C=C\C/C=C\C/C=C\C/C=C\CCCCc1cc(O)cc(O)c1,,0
29816,CMNPD29817,COC(=O)NCCc1ccccc1C(=O)NCCc1ccccc1C(=O)NCCc1ccccc1C(=O)NCCc1ccccc1C(=O)NCCc1ccccc1,weak anti-HIV | no AB activ.,1
102,CMNPD103,C=C1CCC(Br)C(C)(C)C12CCC(C)(Cl)C(Br)C2,,0
307,CMNPD308,CCCOP(=S)(N/N=C(C)/C(C)=N/O)OCCC,,0
647,CMNPD648,C#C[C@@H](O)[C@H]1C[C@H]2O[C@]3(C[C@H]2O1)OC([C@H](Br)CC)C[C@@H]3Br,,0
575,CMNPD576,C=C1[C@@H](O)CC[C@@]2(C)CCC3=C(C(C)C)CC[C@]3(C)C[C@]12O,,0
440,CMNPD441,COc1cc(C)c(O)c(C[C@]2(C)[C@H]3CCC(=C(C)C)[C@@H](CCC(=O)O)[C@]3(C)CC[C@H]2C)c1,,0
446,CMNPD447,C/C(=C/Cc1cc(O)cc(C)c1O)CC(=O)C[C@@]1(C)CCC[C@@]1(C)C(=O)/C=C/C(C)(C)O,inhibitor of cell division,0
568,CMNPD569,C=C1CC[C@@H](O)[C@@]2(C)CC=C3C(C(C)C)=CC[C@]3(C)C[C@]12O,,0
763,CMNPD764,CC(=O)O[C@H]1[C@@H](C(C)C)CC[C@@]2(C)[C@H](Br)CC[C@@](C)(OC(C)=O)[C@H]12,,0
30949,CMNPD30950,O=c1c2c(O)cc(O)cc2oc2cc(CO)cc(CO)c12,IA vs. 8 HTCLs | NT vs. HIV-1.,1
25011,CMNPD25012,C=C1C[C@H](OC(C)=O)[C@H]2[C@H](C(C)(C)OC(C)=O)CC[C@]2(C)/C=C/[C@H](C)CC[C@@H]1O,evaluated in anti-HIV-1 assay system,1
379,CMNPD380,CCCCCCCCCCCCC/C=C/C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC,,0
419,CMNPD420,CC(C)=CCC/C(C=O)=C/CC/C(C)=C/CC/C(C)=C/CC1=CC(=O)C=C(C)C1=O,,0
254,CMNPD255,COC(=O)C1=c2\[nH]c3ccccc3\c2=C\C(C(=O)OC)=c2\[nH]c3ccccc3\c2=C\1,,0
726,CMNPD727,CC1=CCC23C(C1)OC(Br)(C=C[C@@]2(C)O)C3(C)C,,0
59,CMNPD60,C[C@@]1(/C=C/Cl)C[C@@](Br)(CCl)[C@H](Cl)C[C@@H]1Cl,,0
349,CMNPD350,CCCCCCCC/C=C/CCCCCCCC(=O)OCC/C(=C/OC(C)=O)C(C/C=C(\C)C#CC=C(C)C)OC(C)=O,,0
606,CMNPD607,C#C/C=C/C[C@H]1O/C(=C(/Br)CC)C/C=C\C[C@H]1Cl,,0
611,CMNPD612,C#C/C=C/CC1O/C(=C(\Br)CC)C[C@H]2O[C@H]2C[C@H]1Cl,,0
314,CMNPD315,C=C1C/C(=C\C(=O)N2CC(OC)=CC2=O)N(C)C1=O,,0
98,CMNPD99,C=C1C[C@H](O)[C@H](Br)C(C)(C)[C@@]12CCC(C)=C(Cl)C2,,0
781,CMNPD782,C=CC(C)(O)CC[C@H]1[C@]2(C)CC[C@@H](Br)C(C)(C)[C@H]2CC[C@@]1(C)O,,0
144,CMNPD145,C=C1C[C@@H](OC(C)=O)/C=C(/C)CC[C@@H]2C(C(OC(C)=O)[C@@H](C=C(C)C)OC(C)=O)=CO[C@H](OC(C)=O)[C@@H]12,,0
276,CMNPD277,O=C(O)c1cc(Br)c(Br)[nH]1,,0
12057,CMNPD12058,C=C(CC[C@@H](C)[C@H]1CC[C@@]2(C)C3C[C@H](OS(=O)(=O)O)C4C[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)C[C@]4(C)C3=CC[C@]12C)C(C)C,inhibitor of HIV-1 integrase,1
416,CMNPD417,COC(/C=C(\C)CCC=C(C)C)C/C(C)=C/CC/C(C)=C/CC1=CC(=O)C=C(C)C1=O,,0
555,CMNPD556,CC(C)=CC/C=C(/C)C1CCC(C)(O)C23CC[C@H](C)C2C13,,0
636,CMNPD637,CC[C@H]1O[C@H]2C[C@H](C=C=CBr)O[C@H]2C/C=C\[C@@H]1Br,,0
406,CMNPD407,CCCCCCCCCCCC1Cc2cccc(O)c2C(=O)O1,anti-inflammatory,0
480,CMNPD481,CC1=C[C@H]2[C@H](C(C)C)CC[C@@H](C)[C@@]2(O)CC1,,0
30801,CMNPD30802,C=C(C)C#CC1=C[C@@H]2O[C@@H](C(C)(C)O)C[C@]23O[C@@H]3[C@H]1O,IA vs. H1N1 | weak inhib. HIV.,1
193,CMNPD194,CC1(C)CCC[C@]2(C)[C@H]3Cc4cc(O)ccc4O[C@]3(C)CC[C@@H]12,,0
258,CMNPD259,CCOCc1cc(O)c(O)c(Br)c1Br,,0
233,CMNPD234,COc1cc(C)c2c(c1)C[C@H]1[C@]3(C)CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]1(C)O2,,0
749,CMNPD750,C=C/C(C)=C\CC1C(=C)CC=CC1(C)C,,0
752,CMNPD753,CC1=CC[C@H]2C(C)(C)[C@@H](Br)CC[C@]2(C)O[C@H]1CBr,,0
546,CMNPD547,CC(C)=CC/C=C(/C)[C@@H]1C[C@@H](O)[C@@H](C=O)[C@@H]1[C@H]1C(=O)C=C[C@H]1C,,0
498,CMNPD499,CC(=O)OC1OC(=O)[C@@H](CCC=C(C)C)[C@H]2CC/C(C)=C/C/C=C(/C=O)[C@H]12,,0
510,CMNPD511,C=C1C[C@H](C(C)=O)[C@H]([C@@H](C)CCC=C(C)C)[C@H]2C(C=O)=CC[C@@H]1C2OC(C)=O,,0
250,CMNPD251,Clc1c[nH]c2ccccc12,,0
530,CMNPD531,C=C(C(O)/C=C/C(C)(O)CO)[C@@H]1C[C@@H](O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
814,CMNPD815,Oc1c(Br)c(O)c(Br)c(O)c1Br,,0
346,CMNPD347,CC(=O)O/C=C(/C=C/OC(C)=O)C(C/C=C(C)/C=C/C=C(C)C)OC(C)=O,toxic,0
25004,CMNPD25005,C=C1[C@H](O)C[C@@H]([C@@](C)(O)CCC=C(C)C)[C@@H](O)[C@@H]2C(C)=CC[C@@H]12,"evaluated against HIV-1, H5N1and LPS-induced NO production",1
794,CMNPD795,O=C/C=C/C=C\C/C=C\CCCC(=O)O,antimicrobial,0
445,CMNPD446,CC1=CC(=O)C(=O)C2=C1O[C@@]1(C2)[C@@H](C)CC[C@@H]2[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]21C,toxic ichthyotoxin,0
681,CMNPD682,CC1(C)C=C2[C@@H](O)CO[C@@H]2C[C@@H]1Br,,0
809,CMNPD810,Oc1cc(O)c(Br)c(O)c1Br,,0
12698,CMNPD12699,Cn1cc2ccnc3c2c1C(=O)C(N)=C3Cl,inhibit the cell fusion of HIV-1,1
541,CMNPD542,CC(C)=CC/C=C(/C)[C@@H]1CC[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
30659,CMNPD30660,C[C@H]1C/C=C\C=C\[C@@H]2CC(=O)C[C@H]2[C@@H](O)/C=C/C(=O)O1,No activation latent HIV. | No inhib. bromodomain-containing protein (BRD4).,1
623,CMNPD624,C#C/C=C\CC(Cl)C1C/C=C\CC(Br)C(CC)O1,,0
507,CMNPD508,CC(=O)OC1C2(C=O)C(C=O)=CC[C@@]1(C)CCC2[C@H](C)CCC=C(C)C,,0
378,CMNPD379,CCCCCCCCCCCCC/C=C/C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCCCCCC,,0
610,CMNPD611,C#C/C=C\C[C@H]1O/C(=C(/Br)CC)[C@H]2C=CC[C@@H]1O2,,0
120,CMNPD121,CC1(C)C[C@@]2(CC[C@H]1Br)O[C@@H]2[C@@H]1C2[C@@](C)(O)CC[C@@H](Br)[C@]2(C)C[C@H]1O,,0
2759,CMNPD2760,CC1=CCC[C@H]2[C@](C)(CC3=CC(=O)C=CC3=O)[C@@H](C)CC[C@]12C,inhibit human immunodeficiency virus (HIV) in vitro,1
14149,CMNPD14150,COC(c1ccc(O)cc1)C1NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)C(O)C(O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)C(C)C(O)C(C)CC(C)C)[C@@H](C)[C@@H](C)C(N)=O)[C@@H](C)OC(=O)[C@@H]2CCCCN2C(=O)[C@@H](CC(N)=O)NC1=O,potent cytoprotective activity against HIV-1,1
655,CMNPD656,C/C(Cl)=C/CC(O)/C(C)=C/Cl,antimicrobial,0
482,CMNPD483,C=C(C)[C@@H]1CC[C@@]2(C)[C@H](O)CC=C(C)[C@@H]2C1,,0
430,CMNPD431,COc1cc(C)c(O)c(C/C=C(\C)CC(=O)/C=C(\C)CCC[C@@H](C)[C@H](O)CC=C(C)C)c1,,0
29423,CMNPD29424,Brc1ccc2c(C(C3=NC[C@H](c4c[nH]c5cc(Br)ccc45)N3)c3c[nH]c4cc(Br)ccc34)c[nH]c2c1,Strong AB activ. vs. Gram (=) | IA vs. Gram (-) | strong anti-HIV activ. vs. 2 strains | mod. activ. vs 1 HTCL,1
599,CMNPD600,CCC(=O)c1oc(Br)c(Br)c(=O)c1Br,,0
813,CMNPD814,Oc1c(Cl)c(O)c(Br)c(O)c1Br,,0
429,CMNPD430,COc1cc(C)c(O)c(C/C=C(\C)CC(=O)/C=C(\C)CCC[C@@H](C)[C@@H](O)C(=O)C=C(C)C)c1,,0
194,CMNPD195,C=C1CC[C@@H]2C(C)(C)CCC[C@@]2(C)[C@@H]1Cc1cc(C(=O)O)ccc1O,,0
649,CMNPD650,C[C@](Cl)(/C=C/[C@H](Cl)[C@](C)(Cl)/C=C/Br)CBr,,0
69,CMNPD70,CC1=C(Br)C[C@@H](Br)[C@](C)(/C=C/Cl)C1,,0
10424,CMNPD10425,CC=C(NC(=O)[C@H](NC(=O)CNC(=O)C(C)(O)C(O)/C=C\C(C)=C\C(C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H]1C(=O)N[C@H](COC)C(=O)NCC(=O)N[C@@H](C)C(=O)NC([C@@H](C)O)C(=O)NC(C(OC)c2ccc(O)cc2)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]1C(C)C)[C@@H](C)[C@@H](C)C(N)=O,cytotoxic | HIV-inhibitory,1
547,CMNPD548,CC(C)=CC/C=C(/C)[C@@H]1C[C@H](O)[C@@H](C=O)[C@@H]1[C@H]1C(=O)C=C[C@H]1C,,0
739,CMNPD740,CC1=CC[C@@]2(C)C(=C(C)[C@H](O)C[C@@H]2C)CC1,,0
466,CMNPD467,C/C(=C\CCC(C)O)CCC/C(C)=C/C(=O)CC(C)C,,0
15,CMNPD16,CCCCC(Br)(Br)C(=O)CI,,0
748,CMNPD749,C=C1CC=CC(C)(C)C1C/C=C(/C)C(CBr)OC(C)=O,,0
6940,CMNPD6941,CCC(C)(C)C(C)CC[C@@H](C)[C@H]1CCC2C3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)C[C@]4(C)C3CC[C@@]21C,inhibit HIV in vitro,1
71,CMNPD72,C/C(=C/Cl)[C@H](Cl)C/C(Cl)=C(/C)[C@H](O)CBr,,0
452,CMNPD453,CC(C)=CC(=O)C/C(C)=C/CC/C(C)=C/CCC1(C)OC1CO,,0
179,CMNPD180,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=CC(O)C=CC1O,,0
619,CMNPD620,C#C/C=C/C[C@@H]1O[C@H](/C=C/C)C/C=C\C[C@@H]1Cl,,0
165,CMNPD166,CC1=C(O)/C(=C/C(C)CCC/C(C)=C/CCc2coc(Cc3ccoc3)c2)OC1=O,,0
305,CMNPD306,CC1=CC(=O)O[C@H]2C[C@H]3O[C@H]4C[C@@H](C)[C@H]5O[C@H]6C[C@H]7O[C@@]8(C)C/C=C\[C@H]9O[C@H]%10C[C@H]%11O[C@H](CC(=O)CCl)C[C@H](O)[C@]%11(C)O[C@@H]%10C[C@@H]9O[C@@H]8C[C@]7(C)O[C@]6(C)CC[C@@H]5O[C@@H]4C[C@]3(C)O[C@H]12,toxin,0
717,CMNPD718,C=C1C[C@H](O)CC(C)(C)[C@@]12CC[C@](C)(Br)[C@@H](Cl)C2,,0
753,CMNPD754,CC(=O)O[C@@H]1C=C(C)[C@H](CBr)O[C@@]2(C)CC[C@H](Br)C(C)(C)[C@H]12,,0
324,CMNPD325,CCCCCCCC(=O)[C@@H](C)C(=O)N[C@H](Cc1ccc(OC)cc1)C(=O)N[C@H](C(N)=O)C(C)C,,0
4938,CMNPD4939,CC1=CCC[C@@H]2C1CC[C@H](C)[C@@]2(C)CC1=CC(=O)C=C(O)C1=O,cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities,1
318,CMNPD319,CCCCCCC[C@@H](C/C=C/CCC(=O)N(C)C/C(=C/Cl)C/C(=C\C(=O)N1CC(OC)=CC1=O)OC)OC,,0
377,CMNPD378,CCCCCCCCCCCCC/C=C/C(O)C(CO)NC(=O)CCCCCCCCCCCCCCC,,0
340,CMNPD341,COc1cc(Br)c(-c2c[nH]c3ccc(Br)cc23)c2c(Br)c[nH]c12,,0
367,CMNPD368,CC(C)=CCC/C(C)=C/[C@@H]1C[C@]1(C=O)[C@@H]1CC=C(C=O)[C@H]1C=O,inhibition of the growth of marine bacteria and fungi | inhibition of cell division in fertilized sea-urchin eggs | inhibition of the motility of sea-urchin sperm | ichthyotoxicity | inhibition of feeding by fish,0
23499,CMNPD23500,CC(=O)CN1Cc2c(cc(O)c3c2O[C@]2(C3)[C@H](C)CC[C@H]3C(C)(C)[C@H](O)CC[C@@]32C)C1=O,inhibit replication of HIV-1,1
45,CMNPD46,CC(=C/Br)/C=C/[C@@H](Cl)[C@](C)(Cl)/C=C/Br,,0
700,CMNPD701,C=C1CC[C@@](C)(C2=CCC(C)=CC2)[C@H]1C,,0
673,CMNPD674,CC1(C)[C@@H](Br)CC2OCC=C2[C@@H]1Cl,,0
284,CMNPD285,C=C1CC[C@@H](Br)C(C)(C)[C@H]1Cc1cc(O)c(Br)cc1OC,,0
109,CMNPD110,CC1(C)O[C@](C)([C@H]2CC[C@@](C)(Br)[C@H](Cl)C2)[C@H](O)C[C@H]1Br,,0
188,CMNPD189,COc1ccc(OC)c(C[C@@]2(C)C3=C(CC[C@@H]2C)C(C)(C)CCC3)c1,,0
27330,CMNPD27331,COc1cc([C@H](Cc2ccccc2)n2cc(C(=O)NC(=O)C[C@H](C)C(=O)O)c(=O)cc2Cc2ccccc2)oc(=O)c1,mod. inhib. HIV-1,1
805,CMNPD806,CCC1=CC/C=C\C/C=C\CC#CCCc2cc(=O)cc(o2)O1,,0
426,CMNPD427,COc1cc(C)c(O)c(C/C=C(\C)CC(O)/C=C(\C)CCCC(C)C(=O)CC=C(C)C)c1,,0
570,CMNPD571,C=C1CC[C@@H](OC(C)=O)[C@@]2(C)CC=C3[C@](C)(CC[C@]3(O)C(C)C)C[C@]12O,,0
19,CMNPD20,CCC[C@@H](OC(C)=O)C1=C(Br)/C(=C/I)OC1=O,antimicrobial | antifungal,0
807,CMNPD808,CCCCC/C=C\C/C=C\C/C=C\CCCCC1CC=CC(=O)O1,,0
428,CMNPD429,COc1cc(C)c(O)c(C/C=C(\C)CC(=O)/C=C(/C)CCCC(C)C(=O)CC=C(C)C)c1,,0
562,CMNPD563,C=C(C)[C@H]1CC(=O)[C@@]2(C)C/C=C(\C)CC/C=C(\C)CC[C@H]12,antimicrobial,0
273,CMNPD274,COc1c(Br)cc(CC(N)=O)cc1Br,,0
567,CMNPD568,C=C1CCC[C@@]2(C)C[C@@H](OC(C)=O)C3=C(C(C)C)CC[C@]3(C)C[C@]12O,,0
632,CMNPD633,C#C/C=C\[C@@H](Cl)C1C2CC3O/C(=C(\Br)CC)C1C3O2,apoptotic,0
139,CMNPD140,C=C1C(=O)O[C@H]2C[C@@H]1[C@@H](OC(C)=O)C/C(C)=C/CC/C(C)=C/CC[C@@]2(C)O,toxic,0
694,CMNPD695,Cc1ccc2c(c1)O[C@@]1(CBr)[C@@H](C)CC[C@@]21C,,0
456,CMNPD457,CC(=O)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C,,0
146,CMNPD147,CC(C)=CCC/C(C)=C/CCc1ccoc1,,0
366,CMNPD367,CC(C)=CCC/C(C)=C/CC[C@H](C=O)[C@@H]1CC[C@H](C=O)[C@@H]1C=O,antimicrobial,0
20202,CMNPD20203,O=C1C(c2ccc(O)c(O)c2)=c2c(c3c(n2CCc2ccc(O)cc2)=C(c2ccc(O)c(O)c2)C(=O)c2cc(O)c(OS(=O)(=O)O)cc2-3)-c2cc(O)c(O)cc21,anti-HIV active,1
679,CMNPD680,CC1(C)[C@@H](Br)C[C@H]2OCC=C2[C@@H]1O,,0
663,CMNPD664,C=C1C[C@](C)(/C=C/Cl)[C@H](Cl)C[C@@H]1Br,,0
178,CMNPD179,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/Cc1cc(O)ccc1O,analgesic,0
578,CMNPD579,C=C1CC[C@@H](OC(C)=O)[C@@]2(C)C[C@@H](O)C3=C(C(C)C)CC[C@]3(C)C[C@]12O,,0
81,CMNPD82,C=CC(Cl)(CBr)CCC(Cl)C(C)(C)Br,,0
117,CMNPD118,CC(C)=C[C@@H]1CC[C@]2(C)[C@@H](Br)CC[C@@](C)(O)[C@@H]12,,0
68,CMNPD69,C[C@]1(Cl)C[C@@](C)(/C=C/Cl)[C@H](Br)C[C@H]1Cl,,0
288,CMNPD289,N=C1N[C@H]2[C@H](COC(N)=O)NC(=N)N3C[C@@H](O)C(O)(O)[C@]23N1,,0
475,CMNPD476,CC1=CC[C@H]2C(C)(CC[C@H]3C(C)(C)[C@@H](O)CC[C@]23C)O1,,0
625,CMNPD626,C#C/C=C\[C@H](Cl)[C@@H](OC(C)=O)[C@H]1C/C=C(/Cl)C[C@H](Br)[C@@H](CC)O1,,0
335,CMNPD336,C=CC[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](C[C@@H](CCCCC)OC)OC)OC)OC)OC)OC)OC)OC,,0
598,CMNPD599,CCC(Br)(Br)c1oc(Br)c(Br)c(=O)c1Br,,0
671,CMNPD672,C[C@]1(Cl)C[C@](C)(/C=C/Cl)[C@@H](Cl)C[C@H]1Br,,0
665,CMNPD666,C=C1C[C@](C)(/C=C/Cl)[C@H](Cl)C[C@H]1Cl,,0
802,CMNPD803,CCCCC/C=C\C/C=C\C=C/C#CCCCC(=O)OCC(O)CO,,0
31548,CMNPD31549,CCC(C)C(=O)O[C@H]1C(C)(C)[C@H]([C@@H](O)C(=O)OC)[C@]2(C)C(=O)[C@@]1(O)[C@@H](O)C1=C3CC(=O)O[C@@H](c4ccoc4)[C@]3(C)CC[C@@H]12,Anti-HIV-1 activ. | weakly cytotox.,1
0,CMNPD1,C1SCSS1,antibiotic,0
29820,CMNPD29821,O=C(NCCc1ccccc1C(=O)NCCc1ccccc1)NCCc1ccccc1C(=O)NCCc1ccccc1C(=O)NCCc1ccccc1,weak anti-HIV | no AB activ.,1
289,CMNPD290,N=C1N[C@H]2[C@H](COC(N)=O)NC(=N)N3C[C@H](O)C(O)(O)[C@]23N1,,0
773,CMNPD774,CC1(C)C[C@@](O)(C[C@@H]2CC[C@]3(C)[C@@H](Br)CC[C@@](C)(O)[C@@H]23)CC[C@@H]1Br,,0
14204,CMNPD14205,Oc1cccc2c1[nH]c1c(C3=C[C@]45CC/C=C\CCCCN6CC[C@@H]3[C@]3(C[C@@H]7/C=C\CCC[C@@H](O4)N7[C@H]35)C6)nccc12,potent antiinflammatory | antifungal | anti-HIV-1 agent,1
20210,CMNPD20211,O=C1C(c2ccc(O)c(O)c2)=C2C(=C(c3ccc(O)c(OS(=O)(=O)O)c3)C(=O)N2CCc2ccc(O)cc2)c2cc(O)c(O)cc21,anti-HIV active,1
690,CMNPD691,Cc1cc2c(cc1Br)C1(C)CCC(CI)(O2)C1C,,0
667,CMNPD668,C[C@]1(/C=C/Cl)C[C@](Cl)(CBr)[C@@H](Br)C[C@H]1Cl,anti-algal,0
391,CMNPD392,CCCC(O)C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)c1c(O)cc(O)cc1O,,0
200,CMNPD201,[C-]#[N+]C1(C)CC[C@@H]2[C@H]([C@@H]3[C@H](C)CC[C@H]31)C2(C)C,,0
12040,CMNPD12041,CC[C@]1(C)C2CC[C@]3(C)C(C[C@H](O)[C@]4(C)C5=C(CCC34)[C@H](C)OC5=O)[C@@]2(C)CC[C@H]1OC(C)=O,inhibitor of in vitro HIV-1 envelope-mediated fusion,1
12756,CMNPD12757,CC(C)C1=CC(=O)[C@@]2(C)C(=O)C[C@@]3(C)C=C[C@@](C)(O)CC[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
12762,CMNPD12763,CC1=CC[C@@H]2[C@H]3C(C(C)C)=C[C@H](O)[C@@]3(C)CC[C@@]2(C)CC1=O,cytotoxic and anti-HIV–1 activity,1
528,CMNPD529,C=C(CC(O)C=C(C)C)[C@@H]1C[C@@H](O)[C@@]2(C)[C@@H]1[C@@H]1[C@H](C)CC[C@@H]12,,0
14952,CMNPD14953,CC1=C2Cc3cc(ccc3O)C(=O)O[C@H](C(C)(C)Br)CC[C@](C)(O)[C@H](Br)CC[C@]2(C)[C@@H](Br)CC1,antibacterial | antifungal | anti-HIV active | cytotoxic to several human tumour cell lines by specific induction of apoptosis,1
29815,CMNPD29816,COC(=O)NCCc1ccccc1C(=O)NCCc1ccccc1C(=O)NCCc1ccccc1C(=O)NCCc1ccccc1,weak anti-HIV | no AB activ.,1
217,CMNPD218,C=C1CC[C@@H]([C@H](C)CCC=C(C)C)[C@@H](O)[C@@H]2C(C)=CC[C@@H]12,,0
448,CMNPD449,C=CC(C)(C)c1ccc(O)c(CC=C(C)C)c1,,0
670,CMNPD671,C[C@@]1(Cl)C[C@@](C)(Cl)[C@@H](Br)C[C@H]1/C=C/Cl,,0
436,CMNPD437,Cc1c(O)cc2c(c1C)O[C@](C)(CCCC(C)CCCC(C)CCCC(C)C)CC2,,0
12748,CMNPD12749,CC(C)C1=C[C@H](O)[C@@]2(C)CC[C@@]3(C)C[C@H]4O[C@@]4(C)CC[C@@H]3[C@@H]12,cytotoxic and anti-HIV–1 activity,1
299,CMNPD300,N=C1N[C@H]2[C@H](COC(N)=O)N(O)C(=N)N3C[C@H](OS(=O)(=O)O)C(O)(O)[C@]23N1,toxin,0
30804,CMNPD30805,CC1(C)CC(=O)c2cc3c(cc2O1)C[C@H](C(C)(C)O)O3,IA vs. H1N1 and HIV.,1
375,CMNPD376,CCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)CCCCCCCCCCCCCC,,0
723,CMNPD724,CC1=CC(=O)CC(C)(C)[C@@]12C=C/C(=C\Br)CC2,,0
115,CMNPD116,CC1=CCC2(CC1)C(C)=CC[C@@H](Br)C2(C)C,,0
12726,CMNPD12727,C[C@H]1CC[C@@H]2OC(C)(C)CCC[C@@]2(C)[C@]1(O)CCCC1(C)CC2(O)CCC1C(C)(C)C2Cc1cc(OS(=O)(=O)O)ccc1O,modest cytoprotection against HIV-1,1
44,CMNPD45,CC(=C/Br)/C=C/[C@H](Cl)[C@](C)(Cl)/C=C/Br,,0
390,CMNPD391,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)c1c(O)cc(O)cc1O,,0
488,CMNPD489,C=C1/C=C/[C@H](C(C)C)CCC(=C)[C@@H](OC(C)=O)CC1,,0
54,CMNPD55,C[C@@](Cl)(/C=C/Br)[C@H](Cl)/C=C/C(=C/Cl)C(Cl)Cl,,0
26608,CMNPD26609,COC[C@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)CC(O)/C=C\C(C)CC(C)C)[C@H](O)C(N)=O)[C@H](O)CC(N)=O)[C@H](C)N)[C@@H](C)[C@@H](C)C(N)=O)[C@@H](C)OC(=O)[C@H](C)N(C)C(=O)[C@@H]([C@H](OC)c2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)CNC1=O,potent HIV inhibit. (EC 50 23 nM in HIV-1RF infected CEM-SS T-cells) | less potent cytotox. (IC 50 367 nM) vs host cells.,1
167,CMNPD168,C/C(=C\CCc1coc(Cc2ccoc2)c1)CCCC(C)CC(=O)O,,0
131,CMNPD132,CC(=O)OC(C)(C)[C@H]1C/C=C(\C)CCC2OC2(C)CC/C=C(\C)CC1,,0
509,CMNPD510,C=C1CC[C@H]([C@@H](C)CCC=C(C)C)[C@H]2C(C=O)=CC[C@@H]1C2OC(C)=O,,0
216,CMNPD217,CC1=CCCC(C)(C)C1CC/C(C)=C/CC/C(C)=C/CO,,0
94,CMNPD95,CC1(Cl)CC2OC3(Br)C=C[C@@](C)(O)C2(CC1Br)C3(C)C,,0
395,CMNPD396,CCCCCCCCCCCCCCCC(=O)c1c(O)cc(O)cc1O,,0
73,CMNPD74,CC1=C(Cl)C[C@@H](/C(C)=C\Cl)OC1=O,,0
675,CMNPD676,CC1(C)C=C(C(O)CCl)[C@@H](O)C[C@@H]1Br,,0
443,CMNPD444,Cc1cc(O)cc2c1C[C@@]1(O2)[C@@H](C)CC[C@@H]2[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]21C,,0
398,CMNPD399,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC/C=C1\CC(=O)c2c(O)cc(O)cc2O1,,0
20212,CMNPD20213,O=C(O)Cn1c2c(c3c1=C(c1ccc(O)c(O)c1)C(=O)c1cc(O)c(O)cc1-3)-c1cc(O)c(O)cc1C(=O)C=2c1ccc(O)c(O)c1,anti-HIV active,1
783,CMNPD784,CC(C)[C@@H]1CC=C[C@H]2[C@@H]3[C@](C)(O)[C@@H](O)C[C@H](Br)[C@@]3(C)CC[C@]12CBr,,0
291,CMNPD292,COC(CCC(C)C1O[C@]23CC(OC(=O)CC(C(C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)C1C)c1cc(O)ccc1Br,toxin,0
517,CMNPD518,CC(C)=CCC[C@@]1(C)[C@H]2/C=C(/C)C(=O)C[C@H]3O[C@]3(C)CC[C@@H]21,,0
501,CMNPD502,CC(=O)O[C@H]1C(=O)C2=C1CC/C=C(\C)CC[C@H]2[C@@H](C)CCC=C(C)C,,0
550,CMNPD551,CC(=O)O[C@H]1CC(=O)[C@H]([C@H]2[C@H](C=O)[C@H](O)C[C@H]2/C(C)=C\CC=C(C)C)[C@@H]1C,,0
323,CMNPD324,CCCCCCC/C(C)=C/C(C/C=C/CCC(=O)O)OC,,0
28061,CMNPD28062,CC(=O)OCC1=C[C@H]([C@@H]2[C@@]3(C)CCCC(C)(C)C3=CC(=O)[C@@]2(C)O)O[C@@H]2C=C(C)C(=O)C[C@H]12,"Similar level of induction of latent HIV-proviral gene expression as positive control, prostratin",1
559,CMNPD560,C=C(C)[C@H]1CC(=O)[C@@]2(C)C[C@@H]3O[C@@]3(C)CC/C=C(\C)CC[C@H]12,antimicrobial,0
660,CMNPD661,C=C(C)[C@@H](Cl)C[C@@H](Cl)/C(C)=C/CCl,,0
506,CMNPD507,CC(C)=CCC[C@@H](C)C1CC[C@]2(C)CC=C(C=O)C1(C=O)C2O,,0
701,CMNPD702,C=C1CC[C@@](C)(C2=CCC(CO)=CC2)[C@H]1C,,0
13175,CMNPD13176,COc1cc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4OS(=O)(=O)O)cc3o2)ccc1O,HIV integrase inhibitor,1
744,CMNPD745,CC1(C)O[C@](C)([C@H]2CC[C@@](C)(Br)[C@H](Cl)C2)CC[C@H]1Br,,0
656,CMNPD657,C=C(C)C(Cl)C/C=C(\C)C(Cl)CBr,,0
662,CMNPD663,C=C1C[C@](C)(/C=C/Cl)[C@H](Cl)C[C@@H]1Cl,,0
280,CMNPD281,NC1=N[C@H]2n3c(cc(Br)c3Br)C(=O)N3CCC[C@]23N1,,0
511,CMNPD512,CC(C)=CCCC(C)[C@@H]1CC/C(C)=C/CC/C(C)=C/[C@@H]1O,,0
